Neuromodulation of cerebral blood flow by ter Laan, Mark
  
 University of Groningen
Neuromodulation of cerebral blood flow
ter Laan, Mark
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2014
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
ter Laan, M. (2014). Neuromodulation of cerebral blood flow. Groningen: s.n.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the




Mark ter Laan       
  
The tiling pattern as used on the cover has some special characteristics. It has been one 
of the first non-periodic tilings that were developed by Sir Roger Penrose in the 1970’s.1 
This specific tiling has been constructed to exhibit a reflection symmetry and a fivefold 
rotational symmetry, but is has no translational symmetry (as your every-day tiling does). 
A shifted copy will never match the original. This has been achieved by applying matching 
rules to a set of two rhombus shaped prototiles, in order to generate a non-periodic tiling.
This aperiodicity is a striking contrast to the periodicity found in physiological processes 
like cerebral blood flow velocities, arterial blood pressure and end-tidal carbon dioxide as 
measured in this thesis. The periodicity of these processes allows for mathematical analysis 
that compare for example phases and amplitudes between related processes and try and 
use these differences or correlations to explain the behavior of a physiological system.
1. R. Penrose, The role of aesthetics in pure and applied mathematical research, Bull. Inst. Math. 
Appl. 10 (1974), 266–271.
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La ﬁ losoﬁ a è scritta in questo grandissimo libro, che continuamente ci stà aperto innanzi à 
gli occhi (io dico l’universo), ma non si può intendere se prima non s’impara à intender la 
lingua, e conoscer i  caratteri, ne’ quali è scritto. Egli è scritto in lingua matematica, e i 
caratteri son triangoli, cerchi,  & altre ﬁ gure geometriche, senza i quali mezi è impossibile 
à intenderne umanamente parola; senza questi è un’ aggirarsi vanamente per un’ oscuro 
laberinto.








The brain represents only 2% of the total body weight, yet it receives 20% of the total body oxy-
gen consumption and uses 25% of the total body glucose. In order to reach these demands 15% 
of cardiac output is directed to the brain.(1) The maintenance of cerebral blood fl ow is challenged 
in several ways. First, variable metabolic demands (in time and cerebral area) require variable 
blood fl ow. Second, variable oxygen and glucose supply require variable blood fl ow. Third, vari-
able hemodynamics require adjustments in cerebral blood fl ow to protect the brain from high 
pressure or too low blood supply.
In order to overcome these challenges a complex system of regulatory mechanisms exists known 
as ‘cerebral autoregulation’ (CA). This system is able to maintain cerebral blood fl ow (CBF) at a fairly 
constant level under most physiological circumstances. In some pathological conditions, though, 
cerebral autoregulation is unable to maintain adequate (regional) brain perfusion. This may lead 
to severe brain damage or even death. When certain areas are selectively involved focal neurolo-
gical defi cits will occur, for example during cerebral vasospasm after subarachnoid hemorrhage.
One of the most disputed regulatory mechanisms of cerebral autoregulation is the neurogenic 
regulation of CBF. Peripheral (non-cerebral) parenchymal vascular beds are regulated by sympa-
thetic pathways, but neurogenic infl uence on CBF remains controversial. Since sympathetic tone 
can be electrically modulated, aﬀ ecting peripheral parenchymal blood fl ow, it is interesting to 
know whether electrical neuromodulation can alter CBF.
In this introduction an overview will be given of neurogenic regulation of CBF and of electrical 
neuromodulation and its eﬀ ects on blood fl ow. Aims and scope of this thesis will be presented 
following this introduction.
Neurogenic regulation of cerebral blood fl ow
In the hallmark paper of Lassen in 1959 already the complexity of regulation of CBF was shown. 
(2)  It was demonstrated that autoregulation keeps CBF at a fairly constant level when mean 
arterial pressure is between approximately 50 and 150 mmHg. He demonstrated that the autore-
gulation curve was infl uenced by several mechanisms like cerebral vasomotor responses, arterial 
carbon dioxide pressure, arterial oxygen pressure, cerebral metabolism and neurogenic control. 
Since then a lot of experimental and clinical research has elucidated several of these mechanisms. 
The basis of understanding the neurogenic regulation of cerebral blood fl ow lies in neuroanato-
mical, neurochemical and neurophysiological research explaining the underlying mechanisms. 
Physiologists as well as clinicians have struggled to translate the anatomical and experimental 
evidence to clinical relevance.
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Chapter 1
Anatomical basis of innervation of cerebral vessels
The innervation of cerebral blood vessels has been appreciated since the 17th century (3), the 
sympathetic nature of this innervation has been shown in the 19th century. (4-6) McNaughton 
described three pathways of sympathetic innervation of cerebral arteries. First the innervation of 
vessels in the carotid region by post-ganglionic fi bers from the superior cervical ganglion, second 
the innervation of the vertebrobasilar arteries by fi bers from the stellate ganglion and third in-
nervation of the rostral part of the circle of Willis by fi bers of the stellate ganglion following the 
tunica adventitia of the common and internal carotid arteries. (7) Later in the 20th century advanc-
es in staining and fi xation techniques as well as the development of the electron microscope al-
lowed further investigation of the ultrastructure of perivascular nerves. Two types of innervation 
are distinguished: extrinsic innervation of extraparenchymal arteries and intrinsic innervation of 
intraparenchymal arterioles (fi gure 1).  It was shown that the extraparenchymal arteries are richly 
supplied with nerve fi bers originating from the superior cervical ganglion (sympathetic) the otic 
and sphenopalatine ganglia (parasympathetic) and the trigeminal ganglion (sensory). After pe-
netrating the brain parenchyma and leaving the Virchow-Robin space, this peripheral innervation 
is lost. In the parenchyma the arteries receive neural input from neurons in the brain itself. This 
intrinsic innervation has been linked to the noradrenergic system from the locus coeruleus, the 
serotonergic system of the brainstem raphe nuclei and the cholinergic system of the basal fore-
brain. It is suggested that these subcortical originating fi bers innervate the arterioles, but also 
indirectly infl uence microvascular resistance through interneurons and astrocytes. (8-9)
Physiological role of innervation of cerebral blood vessels
The fact that intracranial blood vessels are shown to be innervated, does not necessarily mean 
that this innervation plays an important physiological role in regulation of vessel diameter (and 
therefore CBF). It has taken physiologists several decades to explain the physiological purpose 
of cerebrovascular innervation, and it has been the subject of considerable controversy, even 
recently. (10-13) The cause of this debate lies in the diﬀ erences between observations in cere-
brovascular response to electrostimulation or sympathicolytic or sympathicomimetic agents in 
laboratory environments. This has lead to contradictory fi ndings, the causes of which have been 
explained by Sandor in detail. (14) The most important causes of these contradictory results and 
subsequent debate seem to be:
 Species diﬀ erences in adrenergic receptor distribution
 The use of elaborative, sometimes inappropriate, methods of CBF measurements
 Variable blood-brain-barrier penetrance in diﬀ erent experimental set-ups
 Confounding mechanisms and substances like hyper/hypocapnia, alkalosis/acidosis, con-
 comitant release of dilator factors and neurotransmitters and the actual arterial blood pres-
 sure (ABP).
The intrinsic system
In animals, stimulation (electrical or chemical) of the dorsal medullary reticular formation, the ros-
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troventrolateral medulla, the dorsal raphe nucleus, the fastigial nucleus, the basal forebrain and 
the centromedian parafascicular thalamus have all been shown to increase cerebral blood fl ow. 
Stimulation of the locus coeruleus resulted in either increase or decrease or no eﬀ ect depending 
on stimulation frequency and species. (15) It has been demonstrated that this eﬀ ect is mediated 
by astrocytes innervated by noradrenergic neurons from the nucleus coeruleus. An increase in 
CBF can be achieved by stimulation of the basal forebrain in vitro. Serotonergic aﬀ erents from the 
raphe nuclei can either increase or decrease CBF depending on the level of stimulation. (9)
Figure 1: Schematic representation of the diﬀ erent types of perivascular nerves. The “extrin-
sic” nerves to cerebral blood vessels at the surface of the brain come from the peripheral ner-
vous system (PNS) and originate either in the superior cervical (SCG), sphenopalatine (SPG), 
or otic (OG) or trigeminal (TG) ganglion. Blood vessels located within the brain parenchyma, 
or the microcirculation, are innervated by “intrinsic” nerve pathways that ﬁ nd their origin in 
the central nervous system (CNS). Inset: schematic representation of the “neurovascular unit” 
as seen at the electron microscopic level. ACh, acetylcholine; CGRP, calcitonin gene-related 
peptide; GABA, gamma-amino butyric acid; NA, norepinephrine; NKA, neurokinin A; NOS, 
nitric oxide synthase; NPY, neuropeptide Y; PACAP, pituitary adenylate-cyclase activating po-
lypeptide; SOM, somatostatin; SP, substance P; VIP, vasoactive intestinal polypeptide; 5-HT, 
serotonin. (Courtesy of: Hamel E. Perivascular nerves and the regulation of cerebrovascular 
tone. J Appl Physiol. 2006;100(3):1059-64)
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The extrinsic system
Animal research has shown that stimulation of sympathetic nerves shifts the upper limit of the 
autoregulation curve, whereas sympathectomy or alpha-blockade shifts the lower limit to a lo-
wer blood pressure. (9, 15) In animal studies it was demonstrated that the parasympathetic in-
nervation from the sphenopalatine ganglion is not involved in autoregulation. In vitro results of 
stimulation of parasympathetic nerves is species dependent. In vivo stimulation of the facial 
nerve seems to increase CBF in humans as well as animals. The parasympathetic nerves do 
not seem to play a role in the basic cerebrovascular responses; it is postulated that it serves a 
protective role in times of cerebrovascular threat. (15)
The trigeminal system plays a role in the trigeminal refl ex, which is a protective mechanisms resul-
ting in an a normalization of arteriolar vessel tone 1 to 2 minutes after constriction (vasoconstric-
tive conditions can trigger the release of peptides like calcitonine gene related peptide (CGRP) re-
sulting in vasodilatation). This mechanism plays a protective role in vasospasm after subarachnoid 
hemorrhage (SAH) in humans. (16-17) Also trigemino-vascular neurons in the trigeminal nucleus 
and the C1 and C2 dorsal roots have been shown to receive input from the ophthalmic branch of 
the trigeminal nerve in animal studies. These pathways are possibly involved in pain and vascular 
changes in migraine and cluster headache by ways of a system including the release of CGRP and 
activation of trigeminal aﬀ erents. (18-20)
The trigemino-cardiac refl ex (TCR) resulting in cardiac dysrythmia, arterial hypotension, apnea 
and/or gastric hypermotility can be triggered by stimulation of any of the sensory branches of 
the trigeminal nerve. It is thought that the parasympathetically mediated cardiac eﬀ ects as well 
as the sympathetically mediated systemic hypotension are modulated by the trigeminal system 
in the lower brainstem. However the connections between the trigeminal and autonomic system 
are unknown. (21)
Paradigms used to measure or challenge CBF and CA
CBF can be estimated in several ways. A comparative review can be found elsewhere. (22) Early 
studies used the Kety-Schmidt method which applies a ten-minute period of inhalation of 15% 
N2O and determines brain uptake from the venous and arterial N2O concentration - time curves. 
(23)  This technique was modifi ed in 1953 to achieve results within 20 minutes. (24) Also radioiso-
topes have been used, calculating CBF from brain-uptake of isotopes as detected by scintillation 
detectors or single photon emission computer tomography (SPECT). These methods suﬀ er from 
the fact that extracranial circulation cannot be totally separated from intracranial circulation (al-
though the contamination in the N2O method is only about 6.5% (23)), so diﬀ erences in CBF could 
be either obscured or overestimated. This problem has been overcome using [15O]H2O-PET (pos-
itron emission tomography) to quantitatively assess CBF with high spatial resolution. (25)  Some 
groups use magnetic resonance angiography (MRA) or digital subtraction angiography (DSA) to 
Chapter 1
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estimate fl ow in cerebral vessels based on contrast enhancement or size of the vessel. These 
methods are unable to detect small eﬀ ects, and translation of radiological fi ndings to physiology 
is diﬃ  cult. 
The N2O-method as well as methods using radioisotopes and radiological methods take time, so 
immediate eﬀ ects are hard to measure. Larsen et al. showed that transcranial Doppler sonogra-
phy (TCD) can be used as an indirect way to determine CBF by measuring CBF velocity (CBFV). 
(26) This method is non-invasive and can be performed in real-time, but is not reliable when the 
diameter of the insonated vessel changes. Another more recently applied method to estimate 
CBF is by the use of near infrared spectroscopy (NIRS). NIRS can provide quantitative data on 
changes in CBF, but provides less exact qualitative data, and only allows assessment of regional 
CBF. (27) Also, NIRS accuracy might suﬀ er from contamination of the signal by extracranial signals 
from the scalp, which can suﬀ er marked vasoconstriction induced by systemically acting agents. 
(28)
All the above mentioned methods can be used to determine CA, since eﬀ ects of changes in ABP 
on CBF(V) can be determined. Several paradigms have been applied to do so. The thigh cuﬀ  
technique creates a sudden drop of ABP by 20% for about 10 seconds, so the eﬀ ects on CBF can 
be measured, as applied in analysis of carotid artery stenosis. (29) Lower body negative pressure 
(LBNP) can induce longer periods of decreased ABP or oscillating ABP, which is being used in the 
analysis of orthostatic hypotension. Also the Valsalva maneuver can be used to elicit a relative 
standard transient decrease in ABP and to analyze the response of CBFV. (30) Other methods try 
to elicit a sympathetic response, for example by head-up tilt, hand-grip or exercise. Because of the 
profound eﬀ ects of CO2 concentration on CBF (31), changes in blood CO2 concentrations induced 
by hyperventilation or by carbogen (a CO2 /O2 mixture)  inhalation have also been used to assess 
CBF vasoreactivity. (32)
Possibly the most important development in understanding CA is the study of dynamic cerebral 
autoregulation. Static CA is the steady-state relation between CBF and ABP, whereas dynamic CA 
represents the transient response of the CBF–ABP relationship. This concept is based on obser-
vations of relatively fast recovery of CBF (within seconds) when it is being challenged by (e.g.) a 
sudden decrease in ABP. Especially the use of TCD (with its high temporal resolution) has allowed 
for the study and subsequent mathematical modeling of dynamic CA. (33-36) It has been shown 
that transfer function  analysis (a mathematical representation of the relation of in- and output 
of a supposedly linear system) can be used to calculate amplitude gain and phase shifts in the 
frequency domains of the signals (after a Fourier transform of the signals). An increased amplitude 
gain and a decreased phase lead of CBFV to MAP curves has been associated with decreased CA. 
Both spontaneous blood pressure  fl uctuations and fl uctuations induced by maneuvers such as 





Evidence of neurogenic autoregulation in humans
Most studies concerning parasympathetic eﬀ ects on CBF report eﬀ ects of (e.g. vagus nerve) 
stimulation on regional CBF as a means of detecting neuronal activity. Studies on general CBF and 
parasympathetic pathways are of poor quality and diﬃ  cult to interpret because of confounding 
factors (concomitant drug use and CO2 was not measured), so no conclusions can be drawn. 
(37-38)
Studies on the role of trigeminal pathways in CBF suggest that the trigeminal fi bers have a role in 
keeping middle cerebral artery (MCA) vascular tone. A block of trigeminal pathways (ablation or 
electrical) seems to increase MCA diameter which results in increased CBF while MCA blood fl ow 
velocity decreases. (39-41)  This is consistent with trigeminal ganglion ablation and stimulation stud-
ies in animals that show that trigeminal pathways play a role in cerebral vasodilatation. (42-44)
Studies on the role of sympathetic pathways and sympathetically active agents on CBF are abun-
dant. Often, though, the eﬀ ects of these pathways or agents on CBF are inseparable from the 
eﬀ ects on hemodynamics that in itself can result in changes in CBF. This subject will be addressed 
more extensively in the next chapter.
 
Electrical neuromodulation
Spinal cord stimulation (SCS) is widely used in the treatment of pain. Although several mech-
anisms have been proposed, its exact mechanism of action remains unclear. (45-46) At least 
part of the eﬀ ects of SCS is mediated by the sympathetic nervous system, as shown by the fact 
that sympathetically mediated pain (e.g. visceral pain and complex regional pain syndromes) 
responds better than nociceptive pain to SCS treatment. (45) In addition, it has been demonstrat-
ed that SCS has autonomic (side-) eﬀ ects, such as increasing peripheral blood fl ow in Raynaud 
phenomenon, peripheral ischemic pain, coronary disease and complex regional pain syndromes. 
(45, 47-48) Since the sympathetic fi bers are located ventrally in the spinal cord and SCS electrodes 
are placed dorsally, these ventral fi bers are not located within the electrical fi eld. Therefore these 
sympathetic eﬀ ects are most likely indirect, e.g. via antidromic pathways. (45)
Transcutaneous electrical neurostimulation (TENS) has been used since 1974 to test the tole-
rance for stimuli in the work-up for SCS. (49) Some of the eﬀ ects seen in SCS, can be produced 
by TENS as well. Eﬀ ects on peripheral blood fl ow have been shown, as well as increased coronary 
perfusion. (50) An experiment on autonomic cardiovascular refl exes demonstrated a decreased 
sympathetic response when using TENS. (51)  Since the sympathetic eﬀ ects as shown by SCS are 
likely indirect eﬀ ects of the electrical stimulation, we postulate that TENS produces these eﬀ ects 
in the same way.
In several studies an increase of CBF has been described as a result of cervical SCS. (52-55) Con-
sidering SCS exhibits sympathetically mediated eﬀ ects elsewhere, and since cerebral vasculature 
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is highly sympathetically innervated, probably this innervation plays a role in the eﬀ ects of SCS 
on CBF. Patel suggested that this eﬀ ect is mediated via a central pathway. This pathway involves 
brainstem vasomotor centers that connect with the cerebral microvasculature through intrin-
sic nerve pathways. In experiments on rats, he showed that surgical sympathectomy failed to 
infl uence the CBF response caused by cervical SCS, while transsection of the spinal cord at the 
cervicomedullary junction completely abolished all increases in CBF. (56) Taken into account the 
eﬀ ect of TENS on peripheral blood fl ow, and its (indirect) eﬀ ect on sympathetic tone, TENS should 
be able to alter CBF, analogous to SCS. As such, TENS and SCS could be a useful adjunct in the 
treatment of cerebrovascular disease.
 
Summary
A tight regulation of CBF is necessary because of the variable, but high, metabolic demands of 
the brain, the variable supply of oxygen and glucose and to protect the brain from hemodynamic 
insults. Cerebral autoregulation consists of several mechanisms, of which the neurogenic regula-
tion is the most disputed. Anatomical studies have shown two pathways of innervation of cere-
bral vasculature, but physiological studies in humans have struggled to prove its relevance, even 
though several paradigms have been applied to do so. Especially sympathetic pathways seem to 
contribute to regulation of CBF in humans. It has been shown previously that these pathways can 
be electrically modulated resulting in changes of blood fl ow. This thesis is aimed at fi nding ways 




Aims and outline of this thesis
Aim of the research that is presented in this thesis has been to explore the feasibility and eﬃ  cacy 
of electrical modulation of CBF in order to benefi t SAH patients with vasospasm.
This thesis is build upon the assumption that cerebral vasculature in humans is (in part) sympa-
thetically regulated and that this sympathetic innervation can be electrically modulated. In order 
to give an overview of available literature on the role of the sympathetic nervous system in regu-
lation of cerebral blood fl ow, a review is presented in chapter 2. Our research has been aimed at 
exploring new therapeutic options for impaired cerebral perfusion, especially in the case of cere-
bral vasospasm after subarachnoid hemorrhage. In the course of the experiments, we have devel-
oped a laboratory set-up including several simultaneous hemodynamic and respiratory meas-
urements as well as transcranial Doppler sonography and near-infrared spectroscopy in order to 
assess CBF. This set-up is presented in chapter 3. A phase 1 study was performed, investigating 
safety of cervical application of the least invasive method of electrical stimulation (transcutaneous 
stimulation with TENS), in healthy subjects. This phase 1 trial is presented in chapter 4. A phase 2 
pilot was subsequently performed in a small group of patients experiencing cerebral vasospasm 
after a subarachnoid hemorrhage. The results of the pilot are presented in chapter 5. In chapter 
6 the observations of patients with cervical spinal cord stimulation using our experimental set-up 
and several paradigms to assess CBF are reported. A summary and general discussion concerning 
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Summary
Background. Cerebral blood fl ow (CBF) is regulated by vasomotor, chemical, metabolic and 
neurogenic mechanisms. Even though the innervation of cerebral arteries is quite extensively 
described and reviewed in the literature, its role in regulation of CBF in humans remains contro-
versial.  We believe that insuﬃ  cient attention has so far been focused on the potential role of the 
innervation of the cerebral vasculature in cerebral autoregulation in humans.
Methods. We have performed an extensive search and selection of available literature on elec-
trical, chemical and surgical manipulations of the sympathetic innervation of cerebral arteries, as 
well as the eﬀ ects of circulating sympathetically active agents on CBF.
Results. Studies on (surgical) ganglion block show a role of sympathetic tone in preventing in-
creases in CBF in humans, which is consistent with the view based on animal studies.  Both direct 
innervation of the cerebral arteries from cervical ganglia and stimulation of adrenergic receptors 
by circulating sympathomimetics prevent sudden increases of CBF associated with hypertension 
and hypercapnia.
Discussion. We postulate that under normal physiological conditions neurogenic control has 
little infl uence on cerebral autoregulation, since other methods of control (vasomotor, chemical, 
and metabolic) are dominant. In severely challenging circumstances, such as delayed cerebral 
ischemia after SAH, these methods might be overwhelmed, increasing the relative importance 








The human brain is exquisitely sensitive to changes in cerebral blood fl ow (CBF). For optimal 
function and survival of neurons in the face of changing physiological conditions, elaborate 
mechanisms have evolved to maintain optimal CBF, and to ensure that regionally and globally a 
favorable balance between oxygen supply and demand is maintained.
Lassen was one of the fi rst to demonstrate the complexities of cerebral autoregulation (CA), the 
process by which CBF is kept at a constant level when mean systemic arterial pressure is between 
approximately 50 and 150mmHg.(1)  It has been demonstrated that the autoregulation-induced 
alterations in CBF are mediated and modulated by several mechanisms such as cerebral my-
ogenic vasomotor responses, arterial carbon dioxide tension, arterial oxygen tension, cerebral 
metabolism and neurogenic control. In healthy subjects, the lower limit of CA was shown to be 
variable.(2) As a result there is no clear evidence to inform decisions on minimum acceptable in-
tra-operative systemic arterial pressures, in healthy patients, let alone those with cerebrovascular 
disease requiring anesthesia.  There are several pathological situations causing alterations in CBF 
as a result of dysregulation, where our knowledge is incomplete. For example, the dysautore-
gulation seen after acute and chronic ischemic stroke results in impaired CBF and is associated 
with subsequent and structural changes. (3-4) Another example is delayed cerebral ischemia after 
subarachnoid hemorrhage (SAH), causing signifi cant delayed morbidity and mortality after SAH. 
Even though a vast amount of research has been conducted on potential methods to prevent 
and treat delayed cerebral ischemia, nimodipine remains the only treatment proven to improve 
outcome. (5) 
The myocardial blood fl ow is also subject to autoregulation; and here manipulations (decreases) 
of sympathetic tone of the myocardial vasculature (by electrical stimulation) have been shown 
to improve myocardial blood fl ow and clinical outcome in patients with myocardial ischemia 
responding poorly to traditional pharmacological coronary vasodilatory therapy.(6-8) Two types 
of innervation of cerebral vessels are distinguished: extrinsic innervation of extraparenchymal 
arteries (from cervical ganglia, otic and sphenopalatine ganglia and trigeminal ganglion) and 
intrinsic innervation of intraparenchymal arterioles (from brain stem nuclei such as the nucleus 
coeruleus). (9-10)  The question arises whether manipulation of the innervations of the cerebral 
arteries can infl uence CBF in a way comparable to improvement of myocardial blood fl ow. If these 
manipulations can indeed infl uence CBF, then this suggests that these manipulations might form 
the basis of a therapeutic intervention in patients who suﬀ er regional cerebral ischemia as a result 
of a thrombotic stroke or from delayed ischemia after subarachnoid hemorrhage. 
The anatomy and physiology of cerebrovascular innervation have been described in chapter 1. 
Also it was shown that cerebrovascular innervation remains the subject of considerable con-
troversy. This debate is due to the diﬀ erences observed in cerebrovascular response to either 
electrical stimulation or pharmacological agents in laboratory environments. This has led to con-
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tradictory fi ndings, the causes of which have been summarized by Sandor in detail (11), and have 
been paraphrased in chapter 1.
We have searched the literature for studies that avoid these confounds or correct for them. We 
have focused on human studies, because the diﬀ erences in species (receptor distribution and 
susceptibility, relative contributions of carotid and vertebro-basilar systems) make it diﬃ  cult, 
if not impossible, to extrapolate animal-data to meaningful clinical data.(11-12) Furthermore, 
ideally, studies should use CBF measurements that are as real-time as possible in homogenous 
populations, adjusting for or correcting confounding conditions (especially CO2).
Our initial goal was to perform a systematic review and a meta-analysis of the data from studies 
meeting the criteria described above. After searching the literature it was apparent that there was 
insuﬃ  cient data for such an approach, and thus we instead will describe (but not analyze) the 
existing literature. The initial search methodology and results are presented in the appendix. The 
focus of this review is the role of the sympathetic nervous system (SNS), since too few studies ad-
dress the infl uence of trigeminal (13-15) and parasympathetic (16-17) pathways in humans. When 
considering the role of SNS on CBF, two main pathways can be identifi ed and will be discussed 
separately: (1) innervation of vessels by sympathetic nerve fi bers originating from the sympathe-
tic ganglia or brain stem nuclei; (2) eﬀ ects of circulating sympathetically acting agents.
 
Paradigms used to measure or challenge CBF and CA
CBF can be estimated in several ways as discussed in the previous chapter. Especially the older 
studies reported in this review have used the Kety-Schmidt method using N2O or its modifi ca-
tion (18-19), radioisotopes and scintillation detectors or single photon emission computer tomo-
graphy (SPECT). Some have used magnetic resonance angiography (MRA) or digital subtraction 
angiography (DSA) to estimate fl ow in cerebral vessels. Transcranial Doppler sonography (TCD) 
or near-infrared spectroscopy (NIRS) have been used in the more recent studies. Techniques and 
draw-backs have been discussed in chapter 1, as well as the paradigms to determine CA. Studies 
reported here have used the thigh cuﬀ  technique, lower body negative pressure (LBNP), the Val-
salva maneuver,  head-up tilt, isometric hand-grip exercise, exercise or hyperventilation. Analysis 
of dynamic CA has been applied only in the most recent studies on circulating agents.
 
The eﬀ ects of electrical, chemical and surgical manipulation of sympathetic innervation 
of cerebral arteries
A few studies have investigated the eﬀ ects of electrical stimulation of either the sympathetic 
ganglia or the cervical spinal cord.(20-22) They are of insuﬃ  cient quality to draw conclusions, 
either because the measured eﬀ ects are inseparable from cardiovascular eﬀ ects(20), or insuﬃ  -
cient quantitative data is presented (21-22), or CO2 is not measured.(22)
In studies on sympathetic ganglion blockade (either chemical or surgical), CO2 is not always 
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measured, heterogeneous study-populations (with diﬀ erent pathologies) are sometimes used 
and several diﬀ erent methods of CBF measurement are applied (table 1). Most studies using stel-
late ganglion blockade show an increased cerebral blood fl ow (increased cerebrovascular resist-
ance (CVR) or CBF by N2O method, increased blood fl ow velocities in the middle cerebral artery 
(MCA) by TCD, or improved angiography), most prominently on the ipsilateral side of intervention. 
In 3 studies on ganglion blockade no eﬀ ect on CBF was found. All used a chemical blockade (by 
percutaneous infi ltration of local anesthetic), so possibly the blocks were not complete. (23-25)
Only one study suggests a decrease of CBF after stellate ganglion blockade, showing a signifi cant 
decrease of signal intensity and unchanged size in intracranial arteries. (26) Interpretation of this 
study is diﬃ  cult because quantitative translation of MRA signal changes to CBF is unclear.
All surgical ganglionectomies showed increased CBF (maximum of +20%). Excision of the inferior 
cervical ganglion was shown to reduce CVR; this eﬀ ect is statistically signifi cant while the eﬀ ects 
of surgical excision of the superior cervical ganglion are not. (27-28) Also cerebral angiography 
was shown to improve after superior cervical ganglionectomy combined with carotid perivascu-
lar sympathectomy in patients with vasospasm after SAH. (29) These three studies have in com-
mon that all cervical sympathetic supply of cerebral vessels was disrupted. The study of Jeng et 
al. on T2 sympathectomy, performing measurements 2-4 weeks after intervention, showed in-
creased blood fl ow in the internal carotid artery (ICA) and increased fl ow velocities in MCA. (30)
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The eﬀ ects of circulating sympathetically active agents
Selective eﬀ ects of sympathetic agents on cerebral autoregulation are hard to detect, since car-
diovascular eﬀ ects induced by these agents can in return result in changes in CBF. Therefore  only 
certain types of study design might result in information about the selective eﬀ ects on CBF: (1) 
studies in which the systemic eﬀ ects of a sympathetic agent are restored (by another agent), (2) 
studies in which the systemic eﬀ ects of an autonomic test or sympathetic nervous system activat-
ing activity are blocked or counteracted by an agent and (3) studies in which the sympathetically 
active agent is administered locally in the brain by either intrathecal or intracarotid delivery.
The majority of studies that measure eﬀ ects on CBF after administration of some sympathetically 
active agents do not apply the above mentioned methods (see appendix). The studies that do, 
Table 1: Overview of studies on the eﬀ ects of ganglion blockade on CBF
Legend: F = female, CBF(V) = cerebral blood fl ow (velocity) measurement, CO2 = carbon dioxide meas-
urement, NR = not reported, TCD = transcranial Doppler sonography, N2O = Nitrogen inhalation, MRI = 
magnetic resonance imaging, Xe-IV = Xenon bolus technique, DSA = digital subtraction angiography, 
SPECT = single photon emission computed tomography, NIRS = near-infrared spectroscopy, Y = yes, 
N = no, ABP = arterial blood pressure, ECG = electrocardiogram, SO2 = oxygen saturation, HR = heart 
rate, N2O% = blood nitrogen percentage, pO2 = partial oxygen pressure, glu = glucose, CVR = cerebrovas-
cular resistance, CMR = cerebral metabolism rate, HT = hematocrit, Hb = hemoglobin, CCA = common 
carotid artery, ECA = external carotid artery, ICA = internal carotid artery, inf = inferior cervical ganglion 
s(stellatum), sup = superior cervical ganglion, T2 = thoracic ganglion at level T2. Other = plexus injury, 
sudden deafness, facial palsy and palmar hyperhidrosis, respectively.
Ref. N = %F Age Pathology CBF(V) CO2 Other parameters Ganglion Method Uni-/ 
bilat. 
Effect 
Gupta et al.(31) 20 0 28 Other TCD Y ABP, ECG, SO2, HR Inf Lidocaine Uni ↑ 
Harmel et al.(24) 13 NR 44 Several N2O Y ABP, SO2 Inf Procaine or 
Intracaine 
Bi = 
Ide et al.(32) 8 NR 22 None TCD Y ABP, HR Inf Lidocaine Uni ↑ 
Jeng et al.(30) 68 49 25 Other TCD N Lumen and blood flow 
CCA, ECA, ICA  
T2 Surgical Bi ↑ 
Kang et al.(26) 19 100 46 None MRI N  Inf Mepivacaine Uni ↓ 
Linden(33) 28 NR NR Stroke N2O Y SO2, N2O% Inf Lidocaine Uni ↑ 
Ohta et al.(25) 16 12 NR Other Xe-IV Y ABP, paO2 Inf Mepivacaine Uni = 
Scheinberg(23) 19 NR 47 Stroke N2O N ABP,pO2, glu/O2 use Inf Procaine Uni = 
Shenkin(27) 75 NR 60 Stroke N2O N CVR, CMR(O2), ABP, HT, 
Hb 
Inf / sup Surgical Both ↑ 
Shenkin et al.(28) 7 NR 44 Several N2O Y ABP, SaO2, SvO2, pH, 
CVR, O2 use 
Inf Surgical Bi ↑ 
Suzuki et al.(29) 11 NR NR Vasospasm DSA N  Sup  Surgical Uni ↑ 





6 0 NR None SPECT N  Inf Mepivacaine Uni ↑ 
Yokoyama et 
al.(36) 




especially in those performed on patients (as opposed to healthy subjects), show great hetero-
geneity between studies (in pathology, agents used and CBF measurement) and within popula-
tions. Arterial or end-tidal CO2 (ETCO2) is hardly ever measured.
Studies in healthy subjects that do use methods to counteract the cardiovascular eﬀ ects of sym-
pathetic agents or ganglion blockade, more consistently measure CO2 and always use an imme-
diate (but indirect) way of measuring CBF by TCD (table 2).
 
 
Several of these studies show that sympathetic activity either decreases CBF or attenuates CBF 
increases. For example sympathetic block doubles the CBF increase during the Valsalva maneu-
ver. (45) On the other hand a sympathetic block prevents the decrease in CBF associated with 
head-up tilt.(38)  Also it has been shown that non-selective alpha block (by phentolamine) im-
pairs autoregulatory responses  (CBFV increased 4 times more with phentolamine in the face 
of increased arterial blood pressure (ABP)) (39).  Similarly, intravenous infusion of trimetaphan 
(a so-called ganglion blocker, because it blocks the cholinergic synaptic transmission in sympa-
Table 2: Overview of studies in healthy subjects challenging sympathetic nervous system, all using TCD to 
measure CBFV.
F = female, CO2 = end-tidal or arterial CO2 measurement, NR = not reported, N/A = not applicable, HR = heart rate, 
ABP = arterial blood pressure, CO  = cardiac output, NIRS = near-infrared spectroscopy, Hb = Hemoglobin, sO2 
= oxygen saturation, pO2 oxygen pressure, ECG = electrocardiogram, PaCO2 = arterial CO2 pressure, A = arterial, 
V = venous, BGA = blood gas analysis, HUT = head-up tilt, HV = hyper-/hypo-ventilation,  Exerc. = exercise, VM 
= Valsalva maneuver, LBNP = lower body negative pressure, MP = metoprolol, SGB = stellate ganglion block, 
TM = Trimetaphan, NE = norepinephrine, PO = phentolamine, PR = propranolol, CL = clonidine and PE = 
phenylephrine. Eﬀ ects: 1) increased transfer function gain and decreased phase shift after block, 2) more 
profound CBF increases after block, 3) reduced CO2 reactivity by agonist 
Ref N = % F Age CO2 Other parameters Agents Challenge Effect 
Hamner et al.(37) 11 36 NR Cont. HR, ABP, ECG, flow brachial 
artery 
PO LBNP 1 
Jordan et al.(38) 6 33 29 Forced HR, ABP, ECG, CO TM, PE HUT/HV 2 
Kimmerley et al.(39) 7 28 30 Cont. HR, ABP PO, NE  2 
Lee et al.(40) 9 NR NR Interm. HR, ABP, O2, ECG CL, PE HV 3 
Maekawa et al.(41) 27 52 30 Cont. ABP, ECG, temp, sO2 CL HV 3 
Mitsis et al.(42) 9 25 29 Cont. HR, ABP, ECG TM LBNP 1 
Ogoh et al.(43) 8 0 22 Interm. HR, ABP, CO MP Exerc. No 
Zhang et al., 2002(44) 12 25 29 Cont. HR, ABP, PaCO2 TM, PE  1 
Zhang et al., 2004(45) 9 33 30 Interm. HR, ABP TM VM 2 
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thetic and parasympathetic pathways) increases CO2 reactivity.(38)  A study applying spectral 
analysis on physiological fl uctuations in CBFV and ABP, found no eﬀ ects on transfer function gain 
and phase lead of CBFV to ABP during beta blockade or exercise.(43) Another study showed in-
creased amplitude gain (transfer function analysis) while the phase lead of CBFV to ABP de-
creased during autonomic block with trimetaphan. This eﬀ ect persisted during restoration of ABP 
by the selective alpha1 receptor agonist phenylephrine.(44) Two other studies used repetitive 
LBNP to generate and compare blood pressure oscillations and CBFV oscillations and confi rmed 
the increased transfer function gain and decreased phase shifts suggestive of a deterioration 
of dynamic cerebral autoregulation by phentolamine and during ganglion blockade by trime-
taphan.(37, 42) Clonidine (a selective alpha2-adrenergic receptor agonist) attenuates the increase 
of CBF associated with hypercapnia.(40-41) This fi nding is diﬃ  cult to interpret for several reasons. 
Via an agonist action at alpha2-adrenergic receptors, clonidine generally reduces sympathetic 
tone by decreasing norepinephrine release, causing a bradycardia and a lowering of the systemic 
blood pressure. However, it also causes systemic vasoconstriction. (46) Finally, it also causes seda-
tion, (presumed to be mediated via an agonist eﬀ ect on alpha2 receptors in the locus coeruleus), 
and if fl ow-metabolism coupling is intact, then sedation should result in decreased cerebral me-
tabolism and a coupled decrease in cerebral blood fl ow mediated by increase cerebro-vascular 
tone, and indeed reduced cerebral blood fl ow velocity has been shown with TCD. (40)
 
Discussion
Studies on the eﬀ ects of sympathetic pathways or sympathetically acting agents are abundant, 
but are very heterogeneous in population, type of CBF measurement, agent or challenge studied. 
End-tidal or arterial CO2 is often not measured.  Most studies cannot diﬀ erentiate reactive chang-
es in cerebral autoregulation as a result of cardiovascular eﬀ ects induced by the studied chal-
lenge or agent, from direct eﬀ ects on cerebral autoregulation. Still, when considering the studies 
on cervical ganglion block, the majority of studies show increased CBF after blockade. Most con-
vincingly, all four studies that did surgically disrupt sympathetic input from the cervical ganglia to 
the cerebral arteries showed increased CBF. Another six studies using a pharmacological superior 
ganglion block showed increased CBF.  Notwithstanding their shortcomings, this shows a role of 
sympathetic tone in preventing increases in CBF. This is consistent with the view (based on animal 
studies) that sympathetic nerve activity limits cerebral vasodilatation during severe hypertension, 
hypoxia and hypercapnia as summarized by Sandor. (11)
Among studies of sympathetically acting agents, those in which a ganglionic block by trime-
taphan was used all showed decreased capability of cerebral autoregulation (both static and 
dynamic) to respond to increased ABP. The same eﬀ ects were found when using the alpha-adren-
ergic antagonist phentolamine. So possibly especially alpha-adrenergic receptors play a signifi -
cant role in cerebral autoregulation, which is further substantiated by the fi nding that the alpha2-
adrenergic agonist clonidine partly prevents CBF increase by hypercapnia. On the other hand 
oral administration of clonidine gives unpredictable uptake, and clonidine could aﬀ ect CBFV and 
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CO2 response indirectly because of its sedative eﬀ ects (presumed to be mediated by an alpha2-
adrenergic eﬀ ect at the locus coeruleus). The only (methodologically suitable) study showing no 
eﬀ ect of a sympathetically blocking agent on dynamic autoregulation used the beta-adrenergic 
antagonist metoprolol.
Studies on dynamic CA showed the particular importance of analysis on a short time-scale (min-
utes) using transfer function analysis on CBFV and ABP curves. Eﬀ ects of sympathetic control of 
cerebral vasculature could be clearly demonstrated using these methods, suggesting a role of 
the sympathetic nervous system in beat-to-beat regulation of CBF. (37, 42, 44) In our opinion, 
sympathetic activity can be seen as one of the modulators of CA that determine the amount of 
change in CBF that can be achieved when CA is challenged by hemodynamic changes. Without 
challenge, the modulation is only minor.  With maximum sympathetic tone, CBF increases will 
be attenuated whereas decreases cannot be counteracted by this system. If sympathetic tone is 
minimal, CBF increases will not be counteracted by this system anymore. This means that when 
sympathetic tone is too high in a situation of cerebral ischemia, it will be diﬃ  cult to increase 
CBF without “resetting” sympathetic tone, especially when other systems also fail (mechanical, 
metabolic and chemical autoregulation). Possibly, therapeutic measures that decrease the output 
of sympathetic pathways towards the cerebral arteries, can help increase CBF in cases of focal 
ischemia, e.g. in case of delayed cerebral ischemia after SAH.
 
Conclusion
Even though meta-analysis is impossible, both ganglion-blockade studies and studies on systemi-
cally acting sympathetically active agents do tend to show that the sympathetic nervous system 
plays an important role in cerebral autoregulation. Both direct innervation of the cerebral arteries 
from cervical ganglia and stimulation of adrenergic receptors by circulating sympathomimetics 
prevent sudden increases of CBF associated with hypertension and hypercapnia. Conversely, sur-
gical excision of the stellate ganglion appears to provide a modest (maximum of +20%) increase 
in CBF. Studies of chemical ganglion blockade have shown less promising results. It may be that 
under normal physiological conditions, myogenic control of cerebral vasomotor tone is domi-
nant, and that neurogenic control has little infl uence. In severely challenging situations, such 
as cerebral vasospasm, myogenic control might be overwhelmed by pathophysiological factors 
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The Prisma guideline for transparent reporting of systematic reviews and meta-analysis was used 
(http://www.prisma-statement.org/index.htm).
Search strategies
Studies were identifi ed with a search strategy in Medline and Embase. Two broad search strate-
gies using a combination of subheadings and text words were employed. Search 1 focuses on 
innervation of cerebral vasculature, while search 2 focuses on sympathetically acting agents (see 
box). Embase was searched after translation of key terms to Embase syntax. Bibliographies of 
included studies were screened for additional relevant articles.
Eligibility Criteria
Included were fully published (i.e., not in abstract form) studies of CBF or cerebral blood fl ow 
velocity (CBFV) changes in humans as a result of (search 1) any electrical, chemical or surgical 
intervention involving any neuronal pathway or (search 2) any systemically administered sympa-
thomimetic or sympatholytic agent. Eligibility was assessed by reading abstracts and, if necessary, 
whole articles. Excluded were case reports, studies on (regional) CBF as a marker of neuronal 
function, and non-English language articles.
Study selection and quality assessment
One investigator (ML) evaluated citations and abstracts (where necessary) using the eligibility 
criteria. All potentially relevant full-text studies were reviewed for relevance by one reviewer. A 
second reviewer resolved cases of doubt.
Results





Search strategy used in medline: 
Search 1: 
((Neural Pathways[MeSH Terms] OR Neural Pathways) OR (Sympathetic Nervous System[MeSH Terms] OR 
Sympathetic Nervous System) OR (Parasympathetic Nervous System[MeSH Terms] OR Parasympathetic Nervous 
System) OR (Autonomic Nervous System[MeSH Terms] OR Autonomic Nervous System) OR (Ganglia, 
Sympathetic[MeSH Terms], OR Ganglia, Sympathetic) OR (Ganglia, Parasympathetic[MeSH Terms] OR Ganglia, 
Parasympathetic) OR (Trigeminal Ganglion[MeSH Terms] OR Trigeminal Ganglion) OR (Locus Coeruleus[MeSH Terms] 
OR Locus Coeruleus) OR (Raphe Nuclei[MeSH Terms] OR Raphe Nuclei) OR Basal Forebrain OR (Thalamus[MeSH 
Terms] OR Thalamus) OR (Reticular Formation[MeSH Terms] OR Reticular Formation) OR Nucleus Fastigius OR 
Rostroventrolateral Medulla) AND ((Cerebrovascular Circulation[MeSH Terms] OR Cerebrovascular Circulation) OR 
Cerebral Blood Flow OR Cerebrovascular Autoregulation OR Cerebral Autoregulation OR Cerebral Perfusion OR 
Cerebral Vasoregulation OR Cerebrovascular Reactivity) 
Search 2: 
(("Adrenergic Agents"[Mesh Terms] OR "Adrenergic Agonists"[Mesh Terms] OR "Adrenergic alpha-Agonists"[Mesh 
Terms] OR "Adrenergic alpha-1 Receptor Agonists"[Mesh Terms] OR "Adrenergic alpha-2 Receptor Agonists"[Mesh 
Terms] OR "Adrenergic Antagonists"[Mesh Terms] OR "Adrenergic Alpha Antagonists"[Mesh Terms] AND 
"Adrenergic alpha-1 Receptor Antagonists"[Mesh Terms] OR "Adrenergic alpha-2 Receptor Antagonists"[Mesh 
Terms] OR "Adrenergic beta-Agonists"[Mesh Terms] OR "Adrenergic beta-1 Receptor Agonists"[Mesh Terms] OR 
"Adrenergic beta-2 Receptor Agonists"[Mesh Terms] OR "Adrenergic beta-3 Receptor Agonists"[Mesh Terms] OR 
"Adrenergic beta-Antagonists"[Mesh Terms] OR "Adrenergic beta-1 Receptor Antagonists"[Mesh Terms] OR 
"Adrenergic beta-2 Receptor Antagonists"[Mesh Terms] OR "Adrenergic beta-3 Receptor Antagonists"[Mesh Terms] 
OR "Sympatholytics"[Mesh Terms] OR "Sympathomimetics"[Mesh Terms] OR "Ganglionic Blockers"[Mesh Terms] OR 
"Ganglionic Stimulants"[Mesh Terms]) OR ("Adrenergic Agents"[All Fields] OR "Adrenergic Agonists"[All Fields] OR 
"Adrenergic alpha-Agonists"[All Fields] OR "Adrenergic alpha-1 Receptor Agonists"[All Fields] OR "Adrenergic alpha-2 
Receptor Agonists"[All Fields] OR "Adrenergic Antagonists"[All Fields] OR "Adrenergic Alpha Antagonists"[All Fields] 
AND "Adrenergic alpha-1 Receptor Antagonists"[All Fields] OR "Adrenergic alpha-2 Receptor Antagonists"[All Fields] 
OR "Adrenergic beta-Agonists"[All Fields] OR "Adrenergic beta-1 Receptor Agonists"[All Fields] OR "Adrenergic beta-
2 Receptor Agonists"[All Fields] OR "Adrenergic beta-3 Receptor Agonists"[All Fields] OR "Adrenergic beta-
Antagonists"[All Fields] OR "Adrenergic beta-1 Receptor Antagonists"[All Fields] OR "Adrenergic beta-2 Receptor 
Antagonists"[All Fields] OR "Adrenergic beta-3 Receptor Antagonists"[All Fields] OR "Sympatholytics"[All Fields] OR 
"Sympathomimetics"[All Fields] OR "Ganglionic Blockers"[All Fields] OR "Ganglionic Stimulants"[All Fields]) AND 
("humans"[MeSH Terms] AND English[lang])) AND (("cerebrovascular circulation"[MeSH Terms] OR "cerebrovascular 
circulation"[All Fields]) OR "cerebral blood flow"[All Fields] OR "cerebrovascular autoregulation"[All Fields] OR 
"cerebral autoregulation"[All Fields] OR "cerebral perfusion"[All Fields] OR "cerebral vasoregulation"[All Fields] OR 
"cerebrovascular reactivity"[All Fields] AND ("humans"[MeSH Terms] AND English[lang])) AND ("humans"[MeSH 
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Figure 2: Prisma flow chart of search 2 
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An experimental set-up to 
modulate the sympathetic nervous 
system in order to augment 
cerebral blood  ow
Adapted from:
Ter Laan M, van Dijk JMC, Staal MJ, Elting JWJ: Electrical modulation of the sympathetic 
nervous system in order to augment cerebral blood fl ow: a protocol for an experimental 





Background. Cerebral blood fl ow (CBF) is regulated by several mechanisms. Neurogenic regula-
tion of CBF has been a matter of debate. Nevertheless several publications reported the eﬀ ects 
of changes in sympathetic tone on CBF. Transcutaneous electrical neurostimulation (TENS) and 
spinal cord stimulation (SCS) have been shown to infl uence peripheral and cerebral blood fl ow 
through a sympathetic pathway. We hypothesize that certain pathological conditions result in a 
relative increase of the neurogenic regulation of cerebral blood fl ow and that this regulation can 
be modulated electrically.
 
Methods. The experimental set-up entails measurements of several parameters that are involved 
in cerebral blood fl ow regulation in patients with cerebral vasospasm after subarachnoid hemor-
rhage. Measurements are obtained at baseline and with stimulation in several frequencies. Ad hoc 
statistical analysis is used to evaluate diﬀ erent settings of the electrical stimulation. With transfer 
function analysis and autoregulatory index calculations, autoregulation can be evaluated.
 
Discussion. The experimental set-up is designed for analysis of neurogenic control of cerebral 
blood fl ow and its modulation in patients with decreased autoregulation. Particularly the ad hoc 






Cerebral blood fl ow (CBF) is determined by cerebral perfusion pressure (CPP) and cerebral 
vascular resistance (CVR) (fi g. 1). Both are regulated by complex mechanisms. CPP depends on 
intracranial pressure (ICP) and mean arterial blood pressure (MAP), which in turn is a resultant of 
cardiac output (CO) and systemic vascular resistance (SVR). CVR is mainly regulated by cerebral 
vasomotor autoregulation, chemo refl ex control (based on arterial carbon dioxide and oxygen 
pressure (PaCO2 and PaO2)), local metabolic processes and nervous activity.(1-4) The anatomi-
cal and physiological basis of neurogenic control of CBF have been described in chapter 1. The 
cerebral vessels are thought to be directly sympathetically innervated in two ways: 1) extrinsic by 
the cervical sympathetic nervous system (analogous to other parenchymal vascular territories) 
and 2) intrinsic by central pathways of the locus coeruleus and other brainstem vasomotor center 
origin. (2, 5-7)
As discussed in chapter 2, several studies have shown changes in CBF as a result of sympathetic 
blockage or modulation in humans.  In physiological resting condition the sympathetic eﬀ ects 
on CVR seem to be minor, but in non-resting and particularly pathological conditions the eﬀ ects 
of sympathetic tone on CVR and consequently CBF become more apparent.(8-10) Indirect eﬀ ects 
of the autonomic nervous system infl uence CBF by altering CPP, e.g. through the arterial and 
cardiopulmonary barorefl exes.(8, 11)
All pathways can be aﬀ ected by pathological conditions. Known examples are arterial hyper-
tension, carotid stenosis, ischemic or hemorrhagic cerebral vascular accidents, traumatic brain 
CBF = CPP / CVR
CPP = MAP ‐ ICP
ICP MAP = CO * SVR
CO = P * SV SVR ≈ 8/π * η * l/r4








Figure 1: Diagram representing the regulatory mechanisms of cerebral blood fl ow. CBF = cerebral blood fl ow, 
CPP = cerebral perfusion pressure, CVR = cerebral vascular resistance, MAP = mean arterial blood pressure, ICP = 
intracranial pressure, CO = cardiac output, SVR = systemic vascular resistance, P = pulse, SV = stroke volume, 8/π * 
η * l/r4 = Poiseuille’s law, where η = blood viscosity, l = vessel length and r = vessel radius, PaCO2 = arterial carbon 
dioxide pressure, PaO2 = arterial oxygen pressure. NB: overlap and interactions between metabolic, chemical, neu-
rogenic and vasomotor autoregulation are not shown.
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injury and cerebral vasospasm. (10, 12-15) It is postulated that in pathological conditions such as 
subarachnoid hemorrhage or ischemic stroke, cerebral autoregulation is (focally) decreased resul-
ting in a relative increase of sympathetic regulation. Therefore, in these conditions sympathetic 
pathways can be more relevant, while in normal resting state they are overruled by stronger 
mechanisms. In these conditions, modulation of the sympathetic nerve activity on cerebral ves-
sels could be of therapeutic importance.
In this context electrical nervous stimulation is appealing, as several studies have shown the ef-
fects of electrical nervous stimulation on peripheral and cerebral blood fl ow (chapter 1). Both 
intrinsic and extrinsic systems have been suggested as the path of action for cervical spinal cord 
stimulation induced increase in CBF.(16-18)  Vascular caliber can directly refl ect adrenergic tone, 
and sympathetic receptor sensitivity, as demonstrated in experimental and animal models of 
vasospasm in subarachnoid hemorrhage (SAH).(19-20) Studies with spinal cord stimulation as 
treatment for patients with coronary vasospasm showed increased coronary perfusion, as well as 
studies using transcutaneous electrical neurostimulation (TENS).(21-23) Also, studies showed an 
inhibitory eﬀ ect of TENS on sympathetically mediated refl exes.(24-26)
The decision to study the eﬀ ects of TENS on CBF is empowered by the assumptions mentioned 
below:
Cervical SCS has the ability to increase CBF.(27-29) This eﬀ ect must be indirect because the 
electrical fi eld does not surpass the sympathetic pathways.(30)
If the eﬀ ect of SCS is indeed indirect, and (antidromic) neuronal pathways lead to modulation 
of sympathetic pathways in the spinal cord, then TENS may have the same eﬀ ect.
TENS has the capacity to increase peripheral blood fl ow via sympathetic pathways.(21, 25)
TENS and SCS are interchangeable in pain management, suggesting they aﬀ ect similar 
pathways.
TENS is non-invasive.
Studies on SCS and CBF have produced no stimulation related complications, only surgery related 
complications such as infection, electrode displacement, etc. The only known complications of 
TENS are skin irritation from the electrodes.
The aim of the study set-up is to investigate the following hypotheses:
Autoregulation is diminished in certain cerebrovascular diseases leading to a relative increase 
of the eﬀ ect of sympathetic tone on CBF.




Since cerebral vasospasm after SAH is often asymmetrical, these patients are ideal candidates to 
test both hypotheses at the same time. When autoregulation is asymmetrically impaired, and CBF 





In this chapter an experimental set-up is described, designed to measure and infl uence the sym-
pathetic regulatory mechanisms of CBF by TENS. As a model, patients with cerebral vasospasm 
can be selected, since in those patients the strong autoregulatory mechanisms are diminished by 
the disease. The set-up is planned to determine CBF, as well as to continuously monitor as many 
factors as possible that infl uence CBF (fi g 1).  These include continuous measurements of blood 
pressure and end tidal carbon dioxide (ETCO2) levels.
Intervention
The subjects are treated with conventional TENS, providing a continuous fl ow of symmetrical 
rectangular biphasic pulses (Schwa Medico, Pierenkemper GMBH; Wetzlarestr. 41-43. D-35630 
Ehringhausen, Germany). Stimulation will be performed at 90% of the highest tolerated current, 
with a pulse-width of 200 microseconds. Stimulation frequencies are 20, 50, 100 and 120 Hz. In 
this way, the entire range of possible TENS frequencies and the most utilized frequencies in cur-
rent TENS treatments are captured. Subjects are supine during the entire experiment. The TENS 
electrodes are applied cervical at the level of the mandible on both sides of the nuchal ligament 
(dermatome C2-C3).
Data collection and integration
Data are collected using a continuous Transcranial Doppler (TCD) monitor (DIGI-LITEtm. Raanana. 
Israel.) to measure cerebral blood fl ow velocities (CBFV) in the middle cerebral artery (MCA) on 
both sides, a plethysmograph for assessing blood pressure and pulse (Finometer-Pro. Finapress 
Medical Systems. Amsterdam. The Netherlands.),  a capnograph (Capnomac Ultima. GE Healthcare. 
Chalfont st Giles. UK) to measure respiration rate and ETCO2 , and a Near Infrared Spectroscope 
(Invos 5100C, Somanetics, Troy, USA) to measure cerebral oxygenation (ScO2). All analogue output 
is routed to a computer via a digitizer. The data are continuously registered using Labview 9.0 
software. Raw data are sampled at 250 Hz. Beat to beat averages are being calculated by using 
the arterial blood pressure curve for triggering. To verify data quality and any relevant changes in 
all variables, both raw data and the calculated averages are plotted in waveform charts that are 
continuously updated.  Both the raw data and the calculated averages will be stored in digital 
format on a PC for further oﬀ -line analysis.
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Ad hoc statistical analysis
In order to determine the optimal frequency of stimulation an ad hoc analysis is performed. Eve-
ry time a data stream, acquired with a specifi c TENS frequency, is compared to baseline. Stable 
sections of data of the same length with least artifacts will be selected for analysis after visual 
inspection. In order to clean the data from artifacts, 5% of top and bottom of data will be deleted, 
replacing those by linear interpolation using in-house written routines in the Matlab environment 
(The Math Works, Inc., Natwick, MA, USA, Matlab 6.5).  A visual inspection of the plotted fi ltered 
data will take place and when necessary the same fi lter can be run a second time or a data section 
with less noise will be selected.
Using the Matlab environment, matrices of data are compared to baseline using the student’s 
T-test since a suﬃ  cient number of observations will be available. An eﬀ ect size is calculated for 
the signifi cant diﬀ erences over time (with baseline as anchor point) in order to determine the fre-
quency with the greatest amount of change from the baseline. If none of the frequencies shows 
an eﬀ ect of more than 20% of the pooled standard deviation (31), no prevalence can be shown.
Analysis of autoregulation
Most patients will have more severe vasospasm on one side. This allows for a comparison of 
dynamic autoregulation.  Since the absolute values for MCA velocity can be infl uenced by many 
factors, including slight alteration of probe position and change in spontaneous autonomic ac-
tivity, a frequency domain analysis will be performed. This is largely independent from minor 
fl uctuations in the absolute values.
The transfer function analysis and the Autoregulatory Index (ARI) are evaluated, estimated from 
spontaneous oscillations in blood pressure and TCD parameters, which results in a phase dif-
ference parameter for the transfer function analysis, and an ARI-index. (32) (33) Normal values 
for the phase diﬀ erence between the MAP and TCD values in the low frequency range are > 50 
degrees. The values for the ARI index range from 0 to 9, with 9 indicating perfect autoregulation, 
and 0 meaning complete absence of autoregulation.
The beat to beat data are resampled at 10 Hz to create a uniform time base. Furthermore, the data 
are detrended, normalized, and subtracted by 1, creating zero-mean signals. A Hanning window 
is applied to the data. At least 5 segments of data with 512 samples each are used to estimate 
the cross-spectra and transfer function between the mean ABP and TCD signals. The phase dif-
ference is determined in the 0.06-0.12 frequency range according to preset rules.(32) For the ARI, 
the inverse fast Fourier transform is calculated, using a cut-oﬀ  frequency of 1.0 Hz. The fi rst 10 
seconds of the impulse response function are integrated to yield an estimate of the step 
response. The resulting curve is compared with the original Tiecks curves by using a least squares 





Regulation of CBF is complex, but can be made apprehensible with the use of a diagram (fi g. 1), 
which has led to the development of an experimental set-up in which most variables are kept 
constant and others are continuously monitored.
The described set-up is based on a few assumptions regarding several factors that play a role in 
CBF regulation. ICP probably remains constant during the experiments, even though fl uctuations 
in CBF and venous pressure can aﬀ ect ICP. We have no reason to suspect blood viscosity changes 
during a measurement. We assume metabolic autoregulatory mechanisms to remain constant 
during the experiments. Oxygenation can be safely assumed to be constant when respiratory 
rate and room oxygen concentration remain constant. In order to not disturb these factors, all 
experiments take place in a quiet room and in supine position.
Several factors (fi g. 1) have to be taken into account before the conclusion can be drawn that 
a change in CBFV measured in the MCA is most probably caused by a change in sympathetic 
activity. First of all, there should be no major changes in blood pressure and PaCO2 (represent-
ed by ETCO2 in our set-up), as changes in these variables can have a profound eﬀ ect on CBFV. 
Furthermore, any large changes in pulse are undesirable, since this might indicate a generalized 
sympathetic activation, and not a more focal sympathetic activation by TENS.  Since we cannot be 
certain if the eﬀ ects of TENS, in case of any eﬀ ect, are mediated by the intrinsic or extrinsic sympa-
thetic pathways, we can expect changes in vessel diameter of the MCA or the cerebral arterioles, 





Measurement Vessel diameter Interpretation 
CBFV ScO2 MCA  Arteriolar   
↑ ↓ ↓ ↔ Vasospasm increase 
↑ ↑ ↔ ↑ Arteriolar dilatation 
↓ ↑ ↑ ↔ Vasospasm decrease 
↓ ↓ ↔ ↓ Arteriolar constriction 
 Table 1: theoretically possible measurements and its most probable 
consequences for vessel diameter, provided MAP and ETCO2 remain 
unchanged. CBFV: cerebral blood fl ow velocity, ScO2: cerebral oxy-
gen saturation, MCA: middle cerebral artery.
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CBF is determined in an indirect way by measuring CBFV in the MCA with TCD. In normal subjects, 
middle cerebral artery diameter is fairly constant, therefore fl ow velocity is proportional to cere-
bral fl ow, and arteriolar diameter is the most important regulator. If arteriolar diameter increases, 
resistance to fl ow will decrease and CBFV (in the MCA) will increase and vice versa. By contrast, 
in cerebral vasospasm the opposite situation exists. In vasospasm, TCD measures intrastenotic 
blood fl ow velocity, and blood fl ow velocity is inversely related to CBF. In this situation, the rela-
tion CBFV = CBF/CSA can be applied, i.e. if MCA diameter increases, CBFV decreases.
Therefore, using this set-up, the fi nding of a decrease or increase in CBFV cannot be interpreted 
in an unambiguous way. Based on TCD alone, even if we include indices of vascular resistance 
(pulsatility), we cannot determine with suﬃ  cient certainty if proximal or distal diameter changes 
may have occurred. We use the measurement of ScO2 (by NIRS) of the frontal lobe (downstream 
of the CBFV measurement in the MCA) as another modality to indirectly estimate changes in 
CBF. Provided brain metabolism, oxygen extraction, blood pressure and PaCO2 remain unaltered, 
an increase in ScO2 indicates vasodilatation and an increase in CBF, while a decrease indicates 
vasoconstriction and a decrease in CBF. Using both TCD and NIRS facilitates interpretation of data, 
provided the other factors remain stable (table 1). Once again, any substantial alterations in MAP, 
ETCO2, and pulse would make interpretation more diﬃ  cult. Still, even though a raised ETCO2 or 
MAP can explain an increase in CBFV, a decrease in CBFV under these circumstances cannot be 
disregarded and must be explained otherwise.
 
Conclusion
This set-up can be used to investigate autoregulation in several cerebrovascular diseases. The 
combined use of TCD to measure CBFV and NIRS to measure ScO2 allows for more reliable con-
clusions on CBF changes than using TCD alone. Besides this, the application of ad hoc statistical 
analysis allows for the optimization of several settings (frequency, current, etc) of electrical stimu-
lation in one session, which facilitates research on electrical modulation of CBF.
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Background. It has been shown that transcutaneous electrical neurostimulation (TENS) redu-
ces sympathetic tone. Spinal Cord Stimulation (SCS) has proven qualities to improve coronary, 
peripheral and cerebral blood circulation. Therefore we postulate that TENS and SCS aﬀ ect the 
autonomic nervous system in analogous ways. In this line of thought, cervical application of TENS 
might be a useful and simple adjunct in the treatment of cerebrovascular disease by improving 
cerebral blood fl ow. Experiments were performed in order to assess whether cervical TENS is safe 
and whether an eﬀ ect on cerebral blood fl ow velocity (CBFV) can be shown in healthy subjects.
Methods. A controlled, non-randomized, phase 1 study was performed with 20 healthy volun-
teers. Cervical TENS was applied in several frequencies, with and without hyperventilation. Contin-
uous registration of arterial blood pressure (ABP), pulse, CBFV (estimated by transcranial Doppler 
sonography(TCD)) and end-tidal carbon dioxide (ETCO2) concentration was performed.
Results. Cervical TENS was well-tolerated by all subjects. Despite small eﬀ ects on heart rate (HR) 
and mean arterial blood pressure (MAP), a signifi cant eﬀ ect on middle cerebral artery (MCA) blood 
fl ow velocity was not demonstrated. No eﬀ ect of age, gender, current or session order on MCA, 
HR or MAP was found. TENS did not infl uence the eﬀ ect of hyperventilation.
Discussion. In these experiments application of cervical TENS is proven to be a safe procedure. 
However, no eﬀ ects on cerebral blood fl ow velocity could be detected, perhaps due to the intact 








As has been described in chapter 1, autonomic pathways are thought to be responsible for the 
eﬀ ects of spinal cord stimulation (SCS) in pain treatment. It was demonstrated that SCS can in-
crease blood fl ow in several circumstances, suggesting an eﬀ ect of the stimulation on sympa-
thetic pathways. Since the sympathetic fi bers are located ventrally in the spinal cord and SCS 
electrodes are placed dorsally, these ventral fi bers are not located within the electrical fi eld. There-
fore these autonomic eﬀ ects must be indirect. Considering that disruption of sympathetic fi bers 
towards the cerebral vessels increases CBF, as shown in chapter 2, possibly electrical stimulation 
works as a temporary block of these pathways. Transcutaneous electrical neurostimulation (TENS) 
has been shown to have eﬀ ects on sympathetic tone and peripheral blood fl ow. (1-2) Possibly 
TENS can alter CBF analogous to SCS which might make this kind of electrical modulation inte-
resting in the treatment of cerebrovascular disease.
TENS either has a direct eﬀ ect on vascular diameter, or has an eﬀ ect on the sympathetic tone. If 
the latter is true, then in resting conditions there should be no eﬀ ect on CBF. Therefore, in order to 
fi nd out whether the sympathetic tone is reduced by TENS, the eﬀ ects of TENS on CBF in hyper-
ventilating subjects is of interest. Given that cerebral blood fl ow in response to hyperventilation 
might partially be sympathetically mediated, this response could be reduced by TENS. (3-4)
As cervical TENS to increase CBF is a novel potential therapeutic application, in this chapter 
the experiments will be described that were performed to assess the eﬀ ects of TENS on CBF in 




The study was designed as a controlled (subjects were their own controls), non-randomized 
phase 1 experiment. Healthy volunteers were recruited from the general public by advertisement 
in the local newspapers. Cerebral blood fl ow velocity (CBFV) can be seen as a representation of 
cerebral blood fl ow (CBF) when the vascular cross-sectional area (CSA) remains constant (CBFV = 
CBF/CSA). CBFV was measured by transcranial Doppler (TCD) of the middle cerebral artery (MCA). 
The trial has been authorized by the local Research Ethical Board.
Sample size calculation
The literature reports inter-individual standard deviation of fl ow velocities as about 15 %(5) and 
the intra-individual standard deviation as 8 %(6). Sample size calculation is based on the require-
ment that a diﬀ erence in fl ow velocities of 20 cm/s (ca 20%) between frequencies 2Hz and 120Hz 
should be detected with a probability (power) of 90% when testing at a signifi cance level of 5% 
two-sided. This results in a sample size of 20.
 
Treatment of subjects
The subjects were treated with conventional TENS, providing a continuous fl ow of symmetrical 
rectangular biphasic pulses (Schwa Medico, Pierenkemper GMBH; Wetzlarestr. 41-43. D-35630 
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Ehringhausen, Germany). Stimulation was performed at 90% of the highest tolerated current, 
with a pulse-width of 200 microseconds. Stimulation frequencies were 2, 20, 50, 100 and 120 
Hz. In this way, the entire range of possible TENS frequencies and the most used frequencies 
in current TENS treatments were captured. Subjects were supine during the entire experiment. 
The TENS electrodes were applied cervically at the height of the mandible on both sides of the 
nuchal ligament (dermatome C2-C3). Doppler probes were applied to the skull for continuous 
registration of fl ow velocity in the MCA (left and right). Continuous registration of pulse and blood 
pressure was recorded by plethysmography.
For the fi rst experiment (fi g. 1) fi ve blocks of measurements took place for each TENS frequency; 5 
minutes of registration without TENS, followed by 5 minutes with TENS (so each TENS frequency 
had its own control-baseline). The order of frequencies was randomized (using the QuickCalcs 
online calculator, GraphPad Software, inc.) in order to correct for possible alteration in time of the 
sympathetic tone during the experiment.














Figure 1: set-up of experiment 1: 5 blocks of baseline measurements followed by 5 minute 
measurement with TENS in randomized frequencies 1 to 5.
Figure 2: set-up of experiment 2: two blocks of base-
line measurements, followed by a measurement with 
hyperventilation either with or without TENS. Order of 
measurements was reversed in half of subjects.
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Chapter 4
The second experiment (fi g. 2) was designed to examine whether TENS infl uences the normal 
cerebral regulation that physiologically occurs in reaction to hyperventilation. In the same way as 
the fi rst experiment, blocks of measurements were recorded, now at a fi xed frequency of 100Hz. 
For practical purposes only one frequency was used for this experiment. The frequency of 100Hz 
was chosen because it has been used in previous TENS experiments to alter blood fl ow in coro-
nary arteries.(7) During this part of the experiment end tidal partial carbon dioxide concentration 
(ETCO2) was measured in the exhaled air as a measure of hyperventilation. Hyperventilation was 
defi ned as a decrease of ETCO2 to 2%. Measurements were performed following the scheme be-
low (in half of the subjects the order was reversed, i.e. fi rst TENS with hyperventilation):
3 min registration with hyperventilation (1 min to achieve a ET CO2 of 2%, 2 min measure-
ment)
10 min registration without TENS/hyperventilation
3 min registration with TENS and hyperventilation (1 min to achieve a ET CO2 of 2%, 2 min 
measuring)
10 min registration without TENS or until baseline variables were approached
 
Data processing
Data was collected using a continuous TCD monitor (DIGI-LITEtm. Raanana. Israel.), a plethys-
mograph for assessing blood pressure and pulse (Finometer-Pro. Finapress Medical Systems. 
Amsterdam. The Netherlands.), an electrocardiograph (Finometer-Pro. Finapress Medical Systems. 
Amsterdam. The Netherlands.) and a capnograph (Capnomac Ultima. GE Healthcare. Chalfont st 
Giles. UK). Near infrared spectroscopy was not yet available to our laboratory at the time of this 
study, therefore the set-up is diﬀ erent from the one described in the previous chapter. All analo-
gue output was routed to a computer via a digitizer. The data were continuously registered using 
Neuromon (incorporating Labview 7.1, National Instruments) software. Before statistical analysis, 
all artifacts were deleted from the data streams (e.g. reduced Doppler signal due to transducer 
dislodgement). In order to clean the data from noise, fi ltering was performed using in-house 
written routines in the Matlab environment (The Math Works, Inc., Natwick, MA, USA, Matlab 6.5). 
Bandwidths for the data were defi ned (50-150 bpm for HR, 5-100 cm/s for MCA, 60-180mmHg for 
ABP and 2-6% for CO2 in resting phase) and top and bottom 10% of data were deleted, replacing 
those by linear interpolation. Next 3 minute data streams were taken from each measurement, 
in each case a stream from -4 to -1 minutes before the start of TENS and a stream from +1 to +4 
minutes after the start of TENS. From the hyperventilation data a stream was taken from -2,5 to 
-0,5 minute from the start of HV and another 2 minute stream as soon as ETCO2 had stabilized 
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Statistical analysis
The purpose of the analysis was to fi nd out (1) the eﬀ ect of diﬀ erent TENS frequencies on cerebral 
blood fl ow and (2) whether the TENS frequency of 100 Hz modifi es the eﬀ ect of hyperventilation 
on cerebral blood fl ow. The data from the fi rst experiment were used to address the fi rst question, 
the data from the second experiment to address the second question. For each TENS frequency 
we subtracted the measurement at the preceding non-TENS session from the measurement with 
TENS and used these “baseline-corrected” diﬀ erences as basic outcomes in the analysis. We used 
all observations from the MCA side which had the highest blood fl ow velocity at baseline as 
measured by TCD. For both questions the analysis consisted of fi tting mixed eﬀ ects regression 
models to the data.(8) For question 1 we have used the TENS frequency (at 5 levels), the order of 
observations, age and gender of the participants as fi xed eﬀ ect explanatory variables. For ques-
tion 2 the fi xed eﬀ ects were TENS frequency (0 or 100), ETCO2, age and gender. Statistical tests 
were carried out at 5% level of signifi cance. The statistical package R was used for computations 
(version 2.8.1; library nlme)
 
Results
A group of 11 females and 9 males, all healthy subjects, completed the experiment, in age ranging 
from 25 to 65 years (median 46.5 years). Two more volunteers participated, but their measure-
ments failed. In one individual the temporal bony windows were insuﬃ  cient to obtain adequate 
MCA signals. In the other, an exceptional amount of noise was perceived on all signals, therefore 
the experiment was aborted.
All volunteers tolerated TENS well, though the highest tolerated current did vary from 10 to 35 
mA. The only adverse events reported by the volunteers were pressure from the cap used to 
position the TCD probes and tingling sensations or dizziness as a result of the hyperventilation. All 
volunteers reached the predefi ned threshold of an ETCO2 of 2% during hyperventilation.
Figure 3A shows box plots with values of MCA blood fl ow velocities, mean blood pressures (MAP) 
and heart rate (HR) without TENS and per TENS frequency for the fi rst experiment. Box plots in Fig. 
3B show diﬀ erences between MCA blood fl ow velocities, MAP’s en HR and their coupled baseline 
values. The mean diﬀ erences and the corresponding confi dence intervals for MCA, HR and MAP 
are shown in Table 1. The eﬀ ect of TENS on MCA was on average 0.78 cm/s (95%-CI: 0.06 to 1.50), 
the eﬀ ects at diﬀ erent TENS frequencies were not statistically signifi cantly diﬀ erent (P=0.80). For 
HR and MAP the eﬀ ects of diﬀ erent TENS frequencies did not diﬀ er (P=0.06 and P=0.14, respec-
tively). Compared to the baseline the HR was signifi cantly lower at 120 Hz, and the MAP was 
signifi cantly higher at 2, 50 and 100 Hz. However, the eﬀ ects are so small, that they cannot be 
















































HR (bpm) MAP (mmHg)
TENS (Hz)
MCA (cm/s)
TENS (Hz) TENS (Hz)
A
B
    MCA                    HR                    MAP  
freq.     effect   95%-conf.int.    effect  95%-conf.int.    effect  95%-conf.int. 
2   Hz    1.019   (-0.277, 2.315)  -0.233   (-1.410, 0.944)  2.133*  ( 0.720, 3.547) 
20  Hz   0.399   (-0.897, 1.695)  -0.453   (-1.750, 0.844)  0.876  (-0.570, 2.322) 
50  Hz    1.247   (-0.049, 2.543)  -0.116   (-1.369, 1.137)  2.565*  ( 1.152, 3.979) 
100 Hz    0.874   (-0.423, 2.170)  0.713   (-0.500, 1.927)  2.180*  ( 0.766, 3.593) 
120 Hz    0.347   (-0.931, 1.661)  -1.844*   (-3.057,-0.631)  0.668  (-0.778, 2.115) 
overall    0.781  (0.060, 1.501) -0.390 (-0.971,0.191) 1.708 (0.825,2.591) 
 
Figure 3: Box plots of mean values of cerebral blood fl ow velocities in MCA (cm/s), heart rate (HR(bpm)) and mean 
arterial pressure (MAP (mmHg)) at the diﬀ erent TENS frequencies (3A: 0 = baseline). The plots in 3B show the dif-
ferences of the mean values when compared to baseline.
Table 1: Diﬀ erences of MCA blood fl ow velocities (MCA), heart rates (HR) and mean arterial 
blood pressures (MAP) for each TENS frequency compared to their coupled baseline values. 
* Signiﬁ cant eﬀ ect.
  














































The infl uence of TENS on human cerebral blood fl ow velocities
Figures 4A and 4B show box plots of values of MCA blood fl ow,  blood pressure and pulse for 
experiment 2: with and without TENS, with and without hyperventilation. No signifi cant eﬀ ect of 
TENS on MCA, HR or MAP on the eﬀ ect of hyperventilation was detected (P-values 0.43, 0.58, 0.31, 
respectively). ETCO2 (diﬀ erence between the measurements with and without hyperventilation) 
was found to be positively related to MCA and negatively to HR (P<0.001).
Because the highest tolerated current varied between volunteers from 10 to 35 mA we have also 
included the current in the fi xed eﬀ ects model. No statistically signifi cant eﬀ ects of current could 
be found.
 
Figure 4: box plots of mean values of MCA blood fl ow velocities (cm/s), heart rate (HR (bpm)) and mean arte-
rial pressure (MAP(mmHg)), for baseline (c1 and c2), hyperventilation (HV) and hyperventilation combined with 
TENS (HV+) (4A). Diﬀ erences of the mean values of TENS with (TENS +) and without (TENS -) hyperventilation, 




We have studied whether TENS can infl uence the cerebral blood fl ow in healthy subjects. We 
postulated that TENS might infl uence cerebral blood fl ow via sympathetic pathways as observed 
in experiments with SCS.(9-16) Also TENS has been shown to increase locoregional blood fl ow 
and sympathetic tone.(1-2)
The purpose of this study was twofold: 1) to fi nd out if the use of cervically applied TENS is safe 
and 2) to fi nd out the eﬀ ect on CBF in healthy subjects.
We suggested TENS might either (indirectly) create a sympathetic response that infl uences CBF, 
or TENS might alter the sympathetic tone. To test the fi rst way of action we performed experiment 
1 in which CBF was measured during stimulation with several TENS frequencies in resting healthy 
subjects. If only sympathetic tone is infl uenced by TENS, subjects in rest will not show an eﬀ ect, 
but subjects that have to apply their autonomous nervous system might. Because the cerebral 
response to carbon dioxide changes might be partially sympathetically mediated (3-4), we have 
also tested whether TENS infl uences the response to hyperventilation.
Because sympathetic tone can easily change during an experiment (an individual can become 
either more or less comfortable during the experiment), we have applied several measures to 
compensate for this eﬀ ect. Firstly we have randomized the order of applied TENS frequencies, 
secondly we have provided each frequency with its own control baseline-measurement and 
thirdly the order of TENS with / without hyperventilation varied.
TENS was tolerated very well by all subjects. No adverse events were found. Also systemic blood 
pressure and heart rate were not aﬀ ected by TENS in a clinically relevant manner.
As for the eﬀ ect of TENS on CBF, no statistically signifi cant eﬀ ects were found for the individual 
TENS frequencies, neither at rest, nor in the hyperventilation experiment. Overall there was a 
small increase of MCA blood fl ow velocity (0.78cm/s) when TENS is compared to rest. The fall in 
MCA blood fl ow velocity as a result of hyperventilation was a little less prominent when TENS was 
applied, but this did not reach statistical signifi cance.
Several explanations can be advanced as to why no eﬀ ect was found. Firstly, of course, there 
might be no eﬀ ect at all. Secondly TENS might not be powerful enough because subjects can 
only tolerate a certain amount of current. However, we did not fi nd a diﬀ erence between volun-
teers that tolerated higher and volunteers that tolerated lower currents. Thirdly we have only 
used one frequency in the hyperventilation experiment; possibly other frequencies give diﬀ erent 
results. Fourthly, one might have to apply TENS for a longer period, although we do not think 
this is plausible, given the results of other TENS studies. Finally, regulatory mechanisms of CBF 
are complex. CBF depends on several parameters including ABP, intracranial pressure (ICP), CO2, 
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O2, and other (auto)regulatory mechanisms. As shown in chapter 2, the sympathetic tone only 
aﬀ ects CBF in a minor way in healthy subjects, and mostly so when challenged. Also the eﬀ ects 
of CO2 might be far stronger than the sympathetic eﬀ ects. (3) This might have masked the eﬀ ects 
of TENS on sympathetic tone.
The power analysis was aimed at fi nding a clinically signifi cant eﬀ ect, therefore with our experi-
ments we can only conclude that there seems to be no such eﬀ ect in a healthy population. This 
does not yet prove that TENS does not infl uence the sympathetic nervous system and CBF, espe-
cially because we did notice a tendency towards less decreased blood fl ow velocities in reaction 
to hyperventilation when TENS was applied.
Possibly an eﬀ ect of TENS is appreciated in patients with disturbed autoregulation, e.g. patients 
with cerebral ischemia or following subarachnoid hemorrhage (with locally disturbed blood-brain 
barrier).  Since cervical TENS did not have a clinically relevant eﬀ ect on systemic blood pressure 
and heart rate, TENS can be safely applied to those patients. We think it is important to further 
investigate the eﬀ ect of TENS on CBF in the presence of a disturbed autoregulation, especially 




In this study we have shown that cervical TENS can be safely applied in healthy subjects. Small, 
clinically not relevant, eﬀ ects on heart rate and ABP were found. No signifi cant eﬀ ects on CBF 
were detected, neither at rest nor during hyperventilation. We think this can be explained by the 
intact cerebral autoregulation in our study population. It would be interesting to fi nd out if more 
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Summary
Background. Transcutaneous electrical neuromodulation (TENS) and spinal cord stimulation (SCS) 
have been shown to increase peripheral and cerebral blood fl ow (CBF). We postulate that certain 
pathological conditions attenuate cerebral autoregulation (CA), which may result in a relative 
increase of the neurogenic regulation of CBF, which can be decreased by electrical modulation.
Methods. Cervical TENS was applied in 10 subarachnoid hemorrhage-patients with TCD-pro-
ven cerebral vasospasm.  Measurements included plethysmography, near infrared spectroscopy 
(NIRS), capnography, and cerebral blood fl ow velocities by TCD. After determining the optimal 
frequency and current, patients were treated with cervical TENS for 2 periods of 3 days, with a 
pause of 1 day in-between.
Results. Only 4 patients tolerated the TENS during the entire experiment. In all other patients 
TENS was applied as much as tolerable. Higher frequencies demonstrated the most prominent 
combined eﬀ ects. End tidal CO2 (ETCO2) was 0.19% lower with TENS oﬀ  then with TENS on (p = 
0.05). Arterial blood pressure (ABP) and pulse were not signifi cantly diﬀ erent over time. CBFV in 
MCA was decreased 8.72 cm/s (p=0.07) while cerebral oxygen saturation was increased 2.66% 
(p=0.01) after the use of TENS.
Discussion. Our data are suggestive of improved cerebral blood fl ow when using cervical TENS 
in patients with cerebral vasospasm.  Several factors could have attenuated the eﬀ ects: the elec-
trodes were poorly tolerated, ETCO2 increased during TENS, few vessels showed prolonged vaso-
spasm and overall fl ow velocities were low. Still an on-oﬀ  eﬀ ect of TENS over time was detected. 









As described in the previous chapters TENS might be able to decrease sympathetic tone and 
therefore increase CBF. Our study on healthy subjects failed to demonstrate an eﬀ ect on CBF as 
illustrated in chapter 4. This is thought to be due to the regulatory eﬀ ects of the intact cerebral 
autoregulation. Studies on SCS and CBF have shown no stimulation related complications, merely 
surgical complications e.g. infection and electrode displacement.
Symptomatic delayed cerebral ischemia (DCI) occurs in up to 30% of patients with subarachnoid 
hemorrhage (SAH) and has been postulated to be associated with cerebral vasospasm. 15-20% 
of them remains disabled or die as a result of progressive ischemia or stroke. Current treatment of 
DCI and vasospasm includes hypervolemia, hypertension and hemodilution (triple H), nimodipi-
ne and direct dilatation of spastic vessels via endovascular angioplasty. There is limited evidence 
for these measures, and despite treatment morbidity remains. (1)
We hypothesize that in the presence of cerebral vasospasm or DCI after SAH, cerebral autoregu-
lation is disrupted, which might open possibilities for TENS to infl uence CBF. If TENS increases CBF, 
it might decrease ischemia and could as such be a useful adjunct in the treatment or prevention 
of DCI after SAH.




Ten patients with cerebral vasospasm were included. Cerebral vasospasm was defi ned as a mid-
dle cerebral artery (MCA) to internal carotid artery (ICA) fl ow velocity ratio of more than 3 (Linde-
gaard index). Patient selection criteria are shown in table 1.
 
The subjects were treated with conventional TENS, providing a continuous fl ow of symmetrical 
rectangular biphasic pulses (Schwa Medico, Pierenkemper GMBH; Wetzlarestr. 41-43. D-35630 
Ehringhausen, Germany). Stimulation was performed at 90% of the highest tolerated current, 
with a pulse-width of 200 microseconds. Stimulation frequencies were 20, 50, 100 and 120 Hz. 
Subjects were positioned supine during the entire experiment. The TENS-electrodes were applied 
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In the fi rst part of the study the optimal frequency for the subject was determined (see section 
statistical analysis). After a baseline data collection, stimulation took place for 10 minutes for each 
frequency.
In the second part of the study changes in study parameters were monitored during a 7 day pe-
riod of stimulation, using the frequency determined in the fi rst part of the study. Patients received 
TENS treatment for 3 days, then it was stopped for one day, and again continued for 3 days. In this 
way eﬀ ects of TENS can be discerned from the physiological decrease of fl ow velocities over time 
in patients with vasospasm. Data were collected as outlined in fi gure 1. During the study-period 
patients received regular care for SAH patients, consisting of frequent neurological examination, 
oral nimodipine administration, triple H therapy, TCD measurements, and intensive care unit ad-
mission or computed tomography scanning if deemed necessary.
The study-protocol was approved by the local Research Ethical board and patients or family 
members gave informed consent.
Inclusion criteria 
Confirmed aneurysmatic subarachnoid hemorrhage. 
Cerebral vasospasm demonstrated by TCD, defined as a MCA/ICA ratio >3 
Aneurysm is treated with a surgical or endovascular procedure. 
Age > 18 years. 
Treatment can be started promptly. 
Informed consent signed by patient or family. 
Exclusion criteria 
History of cervical spine or skull-base surgery. 
Known adverse reaction to TENS-pads. 
The presence of any implanted electronic device (including pacemakers). 
Pre-existing disease that can obscure follow-up. 
Unacceptable interference with ECG registration (in case intensive care is necessary). 
Insufficient temporal bony windows 
The use of sympathicomimetic or sympathicolytic agents. 
 Table 1: Patient selection criteria. TCD; transcranial Doppler sonography, MCA; middle cerebral artery, 
ICA; internal carotid artery, TENS; transcutaneous electrical neurostimulation, ECG; electrocardiograp-
hy.
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Figure 1: Study protocol
 
Data collection and integration
We have used the experimental set-up as described in chapter 3 in order  to continuously moni-
tor as many factors that infl uence CBF as possible.(2)
Data was collected using a continuous Transcranial Doppler (TCD) monitor (Pioneer TCD 8080) to 
measure cerebral blood fl ow velocities (CBFV) in the middle cerebral artery (MCA) on both sides. 
Each time the highest fl ow velocities were used in the fi rst session (mostly found around 50mm 
depth) and the subsequent measurements were taken at the same depth. A plethysmograph was 
used for assessing blood pressure and heart rate (HR) (Finometer-Pro. Finapress Medical Systems. 
Amsterdam. The Netherlands.), a capnograph (CapnomacUltima. GE Healthcare. Chalfont st Giles. 
UK) to measure end tidal CO2, and a Near Infrared Spectroscope (Invos 5100C, Somanetics, Troy, 
USA) to measure cerebral oxygenation (ScO2). The NIRS-electrodes were placed bilaterally on the 
forehead, covering mostly middle cerebral artery territory, but also anterior cerebral artery (ACA) 
territory. The data were continuously registered using Labview 9.0 software. Raw data were sam-
pled at 250 Hz. Beat to beat averages were calculated by using the arterial blood pressure curve 
for triggering.
Statistical analysis
In order to determine the optimal frequency of stimulation for each subject, an ad hoc analysis 
was performed. After visual inspection, stable sections of data with least artifacts were selected 
for analysis. In order to clean the data from artifacts, top and bottom 5% of data were deleted, 
replacing those by linear interpolation using in-house written routines in the Matlab environment 
(The Math Works, Inc., Natwick, MA, USA, Matlab 6.5).  Using the Matlab environment matrices 
of data were compared to baseline using the student’s t-test. An eﬀ ect-size was calculated for 
the signifi cant diﬀ erences over time (with baseline as anchor point) in order to determine the 
frequency with the greatest amount of change since baseline. If none of the frequencies showed 
an eﬀ ect of more than 20% of the pooled standard deviation, or changes in MAP, HR or ETCO2 
were responsible for the change in fl ow velocity, no superiority could be shown and 100Hz was 
chosen.(3)
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For the analysis of the frequency data of all patients a multilevel model for left and right side was 
designed using SAS 9.2 software. Measurements were nested in patient, data was adjusted for 
variance of the confounders MAP, HR and ETCO2.
For analyzing the CBFV in the MCA and the ScO2, data were extracted at the left and right side, at 
four diﬀ erent days (0, 3, 4, and 7). A multilevel model was designed where side was nested within 
patient, day was nested within side, and measurement was nested within day. The characteristic 




Between July 2010 and November 2011 eleven patients were included. In one patient the 
measurements failed repeatedly because of severe disease-related agitation. Therefore this 
patient was excluded from further analysis. Another patient refused to continue TENS a few hours 
after the fi rst data collection. All other included subjects (n=9) completed TENS treatment for 7 
days, or until vasospasm disappeared. Characteristics of patients are shown in table 2.
 
 
Only 4 patients tolerated the TENS during the entire experiment. Main causes of failure were dis-
ease related restlessness causing the electrodes to dislodge from time to time and the fact that 
poorly cooperating patients could not tolerate the paresthesias. In all patients TENS was applied 
as much as possible and dislodged electrodes were replaced as soon as possible. All patients 
developed a slight burning of the skin around the sites of TENS application, although this never 
led to stopping the TENS-application.
Table 2: patient characteristics. WFNS: World Federation of Neurological Surgeons grading, Fisher: Fisher 
grade, HC: hydrocephalus, Acom: anterior communicating artery, Pcom: posterior communicating artery 
(Left/Right), MCA: middle cerebral artery, ICA: internal carotid artery.
 
 
Age WFNS Fisher HC Aneurysm Aneurysm 
treatment 
Day first spasm Day inclusion 
1 55 5 4 Y Acom Coil 5 6 
2 51 1 3 Y MCAL Coil 5 7 
3 51 1 2 N PcomR Coil 5 8 
4 53 1 2 Y Acom Coil 3 4 
5 40 1 1 N MCAL Clip 7 8 
6 65 2 4 Y Acom Coil 7 8 
7 55 1 1 N PcomL Coil 3 4 
8 69 2 2 N PcomR Coil 7 10 
9 23 1 1 N ICAR Coil 7 8 




The patients were included as soon as possible after the detection of cerebral vasospasm. Pa-
tient 3 was included only after norepinephrine treatment was no longer necessary, patient 8 
could only be included three days after vasospasm commenced because of technical issues. NIRS 
measurements of patient 10 were not included in the analysis, because severe spasm of the ACA 
resulted in very low cerebral oxygenation, interfering with our measurements of MCA.
TENS frequencies
In 4 subjects 100Hz demonstrated the most prominent combined eﬀ ects (t-test, data not shown), 
in 4 120Hz was superior. In 2 patients no diﬀ erences could be demonstrated and 100Hz was used 
on pragmatic grounds.
When comparing the frequencies used in all patients in a multi-level analysis, no signifi cant dif-
ferences were found in fl ow velocities. There was a small but signifi cantly higher ScO2, though, 
when using TENS in 50, 100 or 120Hz that was most prominent in the latter two frequencies (of 
around 5%, after correction for ETCO2, MAP and HR in a multi-level analysis).
Analysis of TENS treatment
Diﬀ erences in MAP, HR and ETCO2 over time were not signifi cant (fi g. 2), but a trend towards high-
er MAP, HR and ETCO2 was observed during TENS treatment (day 3 and day 7). ETCO2 was 0.19% 
lower with TENS oﬀ  then with TENS on (p = 0.05). MCA blood fl ow velocities and ScO2 (by NIRS) 
are shown in fi gure 3, corrected for variability in MAP, HR and ETCO2 (in a multi-level analysis). 
When comparing CBFV and ScO2 at days 0 and 4 (TENS oﬀ ) with days 3 and 7 (TENS on), CBFV was 

























Day 0 Day 3 Day 4 Day 7 
ETCO2 
Figure 2: Confounders during measurements at day 0,3 4 and 7. MAP; mean arterial pressure (mmHg), HR; heart 
rate p/m, ETCO2; end-tidal carbon dioxide (kPa).
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We have analyzed spastic and non-spastic vessels separately in a four level model. Spasm was
determined as an ICA/MCA ratio >3 on 2 or more occasions (since not all included patients 
showed spasm after inclusion). Diﬀ erences in MCA fl ow velocities (MCAv) were not statistically 
signifi cant, but a trend towards an on-oﬀ  eﬀ ect was found. Signifi cant diﬀ erences were found in 
ScO2 between day 0 and three in the non-spastic vessels and between day 3 and 4 and 4 and 7 
in the spastic vessels (fi gure 4).
When comparing CBFV and ScO2 at days 0 and 4 (TENS oﬀ ) with days 3 and 7 (TENS on), CBFV 
did not signifi cantly change for neither non-spastic nor spastic vessels. ScO2 increased 3.35% 
when TENS was on in non-spastic vessels (p=0.07) and ScO2 increased 2.40% in spastic vessels 
(p=0.06).
As described in chapter 3, also the transfer function analysis and the Autoregulatory Index (ARI) 
were evaluated, estimated from spontaneous oscillations in blood pressure and TCD parameters. 
The combination of minor spontaneous fl uctuations and considerable noise (e.g. by ventricular 
extrasystoles), made this analysis only possible in 4 subjects. In those subjects the consistency of 



















Day 0 Day 3 Day 4 Day 7 
Vessels of all patients (n=18) 
CBFV 
ScO2 
p=0.07 p=0.05 p=0.13 
p=0.4 p=0.2 p=0.06 
cm/s % 
Figure 3: Cerebral blood fl ow velocity (CBFV in cm/s) in middle cerebral arteries of all patients (18 
arteries) and cerebral oxygen saturation (ScO2 in %). P- values are indicated.
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Figure 4: Cerebral blood fl ow velocities and cerebral saturation in spastic and non-spastic vessels 
(territories). Middle cerebral artery fl ow velocity (MCAv) in cm/s, cerebral oxygen saturation in %. No 



















day 0 day 3 day 4 day 7 
Non-Spastic vessels (n=8) 
MCAv 
ScO2 


















day 0 day 3 day 4 day 7 
Spastic vessels (n=10) 
MCAv 
ScO2 
p= 0.007 p= 0.119 p= 0.748 
cm/s % 
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Discussion
Interpretation of TCD and NIRS data
During the measurements at day 0, the higher frequencies showed more convincing eﬀ ects than 
the lower frequencies. Therefore stimulation frequencies of 100 and 120Hz were used. Our data 
show a trend towards decreased MCA fl ow velocities, while oxygenation of the frontal lobe sig-
nifi cantly increased during TENS treatment. This is suggestive of decreased vasospasm and in-
creased CBF. Since ETCO2 increased during TENS, the measured eﬀ ects on CBFV may have been 
attenuated, while eﬀ ects on ScO2 could be overestimated. Even though few eﬀ ects reached sta-
tistical signifi cance in the small study-population, there is an on-oﬀ  eﬀ ect over time. Especially the 
non-spastic vessels seemed to contribute to the signifi cant increase of cerebral saturation during 
TENS treatment, while the changes in fl ow velocities are more prominent in spastic vessels.
CBF was determined in an indirect way by measuring CBFV in the MCA with TCD in our study. As 
explained in chapter 3, during vasospasm, TCD measures intrastenotic blood fl ow velocity, and 
blood fl ow velocity is inversely related to CBF. In this situation, the relation CBFV = CBF/CSA (CSA 
= cross sectional area) should be applied, so if MCA diameter increases, CBFV decreases, while CBF 
increases. So based on TCD alone, it is impossible to determine with suﬃ  cient certainty if proximal 
or distal diameter changes have occurred. Using both NIRS and TCD facilitates the interpretation 
of data, provided that brain metabolism, oxygen extraction, blood pressure and PaCO2 remain 
unaltered.  An increase in oxygenation indicates vasodilatation and an increase in CBF, while a 
decrease indicates vasoconstriction and a decrease in CBF. As said before, even though a raised 
ETCO2 or MAP can also explain an increase in CBFV, a decrease in CBFV under these circumstances 
cannot be disregarded and must be explained otherwise.
Physiological basis of neurogenic control
The anatomical and physiological basis of neurogenic control of CBF have been extensively stud-
ied. The cerebral vessels are thought to be directly sympathetically innervated in two ways: 1) 
extrinsic by the cervical sympathetic nervous system (analogous to other parenchymal vascular 
territories) and 2) intrinsic by central pathways of the locus coeruleus and other brainstem va-
somotor center origin.(4-7) We have postulated that in pathological conditions such as SAH or 
ischemic stroke, cerebral autoregulation is (focally) decreased resulting in a relative increase of 
sympathetic regulation.(2) Therefore, in these conditions sympathetic pathways can be relevant,
while in normal resting state they are overruled by stronger mechanisms. In these conditions, 
modulation of the sympathetic nerve activity on cerebral vessels could be of therapeutic impor-
tance.
In this context electrical nervous stimulation is attractive, since several studies have shown the 
eﬀ ects of electrical nervous stimulation on peripheral and cerebral blood fl ow. Both intrinsic and 
extrinsic systems have been postulated to be the path of action for cervical spinal cord stimula-
tion induced increase in CBF.(8-10) Because both epidural electrical stimulation (by SCS) and cu-
taneous stimulation (TENS) seem to aﬀ ect CBF, an indirect eﬀ ect seems plausible. Possibly sensory 
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input into the dorsal horns modulates the sympathetic pathways running caudally in the spinal 
cord. These sympathetic fi bers exit the spinal cord at the cervico-thoracic level, and run through 
the cervical ganglia towards the cerebral vessels.
Our data suggest that if TENS increases CBF, it does so by means of a peripheral vasodilatation, 
since the increase in ScO2 was more convincing then the decrease in MCAv. Possibly locally in-
creased sympathetic tone causes decreased peripheral CBF (leading to delayed cerebral 
ischemia) which can be reversed by TENS. Even though no signifi cant changes in MCAv could 
be detected, we have found a consistent increase in MCAv and decrease in ScO2 when TENS was 
turned oﬀ  between day 3 and 4 which was reversed when TENS was turned on.
Limitations of this study
This is the fi rst study on the clinical eﬀ ects of cervical TENS in SAH patients. The results comply 
with previous fi ndings of increased CBF in patients treated with cervical SCS. (11-13)
Nevertheless, the study has its limitations. Our patient group is small with considerable inter-in-
dividual variance, so statistical signifi cance is hard to reach and clinical outcome data cannot be 
studied. We did measure confounding factors like MAP, HR and ETCO2, but we were not techni-
cally able to correct them during the measurements. The average changes in these confounders 
were very small, though (fi g. 2). Another problem is that we have chosen to include patients 
when an ICA/MCA ratio of 3 or higher was detected; some patients only reached this once at 
time of inclusion and therefore fewer spastic vessels were studied then was aimed for. Overall, the 
fl ow-velocities in our population were not very high. Another factor that could lead to an under-
estimation of the eﬀ ects of TENS on CBFV is the fact that ETCO2 was slightly higher when TENS 
was on, then when it was oﬀ , which would increase MCA fl ow velocities. On the other hand this 
can cause an overestimation of the eﬀ ects on ScO2.
A technical limitation is the fact that NIRS in our study detects the combined cerebral saturation 
of (part of ) both ACA and MCA territories. Theoretically an increased saturation in ACA territory 
could mask a decreased saturation in MCA territory.
Finally, TENS was tolerated far less than expected in this patient group. Several patients did not 
tolerate the TENS treatment very well, complaining of local paresthesias. Some patients were too 
restless to keep the electrodes in place, even though the cutaneous injuries were mild.
Implications for clinical practice
Our data show that high-frequency cervical TENS has the potential to increase CBF in SAH pa-
tients with cerebral vasospasm, although its mechanism remains unclear. Even though some 
statistically signifi cant diﬀ erences in cerebral saturation were found, these are hardly clinically 
relevant. The largest eﬀ ects (in the on-oﬀ  analysis) on MCA fl ow velocity and cerebral oxygena-
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tion were around 15% and 10% respectively. The clinical feasibility is low, because patients poorly 
tolerated the electrodes.
All in all, we postulate that, based on our results, further research towards more invasive kinds of 
electrical neurostimulation at the cervical level in SAH patients is warranted. Possibly, subcuta-
neous or epidural electrical stimulation will achieve higher electrical currents, resulting in better 
eﬀ ects on CBF. Also, these methods might be better tolerated by SAH patients.
Conclusion
Despite its limitations, cervical TENS increases cerebral oxygenation and shows a trend towards 
decreased MCA fl ow velocities in the presence of cerebral vasospasm after SAH. The benefi cial 
changes found in our study are clinically not relevant, though.
More invasive methods of electrical stimulation are probably better tolerated and can as such be 
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Summary
Background. Spinal cord stimulation (SCS) is recognized to aﬀ ect regional blood fl ow. Less is 
known about the physiological eﬀ ects of cervical SCS on cerebral blood fl ow. Demonstrating a 
substantial eﬀ ect may benefi t the treatment of several cerebrovascular disorders.
Methods. Patients with an implanted cervical SCS were selected from the UMCG neuromodula-
tion registry. Individual stimulation settings that were proven eﬀ ective for pain reduction were 
used during experiments. We have applied the same set-up as described in chapter 3 in order 
to detect changes in CBF. Also, thermography of the hand was performed. Measurements were 
performed switching SCS on and oﬀ  in a resting state, during Valsalva maneuver (VM) and dur-
ing isometric handgrip exercise (IHE). Also dynamic cerebral autoregulation was examined using 
transfer function analysis.
Results. Measurements were completed in four patients. No variations during rest were found, 
but slight changes in hand temperature were detected. Diﬀ erences were detected during IHE 
and VM with SCS on versus oﬀ . A fi ltered autoregulation index was calculated signifi cantly lower 
with SCS on.
Discussion. At rest no changes in CBF as a result of cervical SCS could be shown. The challeng-
es applied, as well as dynamic autoregulation calculations, resulted in a statistically signifi cant 
change, indicative of a slight cerebral arteriolar dilatation. The fi ndings with these methods are 




As noted in previous chapters, spinal cord stimulation (SCS) is known to increase regional blood 
fl ow. It has been applied for its vasodilator eﬀ ects in the treatment of peripheral vascular disease 
and angina. (1) Also, eﬀ ects of SCS in cerebral blood fl ow (CBF) have been reported. (2-6) The 
exact mechanism by which SCS can result in increased blood fl ow is not fully understood. Ani-
mal research has brought forward the role of sympathetic pathways, cerebral autoregulation and 
humoral factors.(3) As shown in chapter 2, sympathetic pathways and circulating sympathetically 
acting agents, in particular alpha adrenergic antagonists, play a role in cerebral autoregulation 
in humans. This eﬀ ect of sympathetic tone on CBF may be relatively increased when cerebral 
autoregulation is hampered in certain pathologic situations, e.g. stroke, traumatic brain injury and 
cerebral vasospasm.
In this chapter we present our experience with several experiments in patients with cervical SCS 
(implanted for unrelated indications), using our set-up as described in chapter 3. Added to this 
set-up we performed thermographic measurements of the hand, to test whether cervical SCS 
infl uences blood fl ow in the hand.
Materials and Methods
The study was approved by the local Research Ethical Board. From the UMCG neuromodulation 
registry patients treated with cervical SCS were selected, in order to be sure that stimulation took 
place above the T1 level were the sympathetic fi bers exit the spinal cord. Seven patients were 
found with electrodes that were positioned mostly cranially of the C7 level. Three patients were 
excluded: in one patient stimulation had been stopped due to lack of eﬀ ect; a second patient had 
his arm amputated on one side, making most of our measurements impossible; a third patient 
refused participation. Characteristics of the four participating patients are shown in table 1.
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All patients had SCS programmed in the settings for treatment of neuropathic pain. During the 
experiments the SCS was switched on and oﬀ , taking measurements in a resting state and during 
the interventions. All experiments were performed in supine position.
Data collection and integration
We have used the experimental set-up as described in chapter 3 in order to continuously monitor 
as many factors as possible that infl uence CBF. (7) Data was collected using continuous Trans-
Cranial Doppler (TCD - Pioneer TCD 8080) to measure cerebral blood fl ow velocities (CBFV) in 
the middle cerebral artery (MCA) on both sides. Each time the highest fl ow velocities were used 
(most frequently found around 50mm depth). A plethysmograph was used for assessing blood 
pressure and heart rate (HR) (Finometer-Pro. Finapress Medical Systems. Amsterdam. The Nether-
lands.), a capnograph (CapnomacUltima. GE Healthcare. Chalfont st Giles. UK) to measure end 
tidal CO2, and a Near Infrared Spectroscope (Invos 5100C, Somanetics, Troy, USA) to measure ce-
rebral oxygenation (ScO2). The NIRS-electrodes were placed bilaterally on the forehead, covering 
mostly MCA territory, but also anterior cerebral artery (ACA) territory. The data were continuously 
registered with Labview 9.0 software (National Instruments Corporation, Austin, Texas, U.S.A.). Raw 
high frequency data were sampled at 250 Hz. Beat to beat averages were calculated by using the 
arterial blood pressure curve for triggering. In some experiments the temperature of the hand 
was measured by thermography (Hotfi nd-L, SDS Infrared Ltd., Hongkong), taking pictures every 
7 seconds.
Table 1: Patient characteristics
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Challenges used and calculations performed to assess e ects on CBF
Data sampling was initially performed with SCS on, followed by sampling with SCS oﬀ . We asked 
patients to perform a Valsalva maneuver (VM) for 15 seconds while recording data. After a short 
resting period this was repeated for a total of three times with SCS on and SCS oﬀ . Autoregulatory 
indices during VM were calculated as suggested by Tiecks et al. (8) Isometric handgrip exercise 
(IHE) was performed by applying handgrip at 30% of maximum power for 5 minutes, while data 
were recorded. VM and IHE could not be performed in the patients with plexus neuropathy, since 
only one hand was available for measurements.
We have assessed the diﬀ erence between the peak systolic and minimum diastolic velocities 
divided by the mean velocity during the cardiac cycle (Pulsatility Index - PI) as an indicator for 
cerebrovascular resistance (CVR). PI is not dependant only on CVR, but on multiple hemodynamic 
variables, making its interpretation more complex. For example PI has been shown to increase 
during plateau waves of increased ICP (while CVR decreases as a result of vasodilatation) as well as 
during hypocapnia (when CVR increases as a result of vasoconstriction). (9) Therefore, in addition, 
CVR was estimated with the formula: ABP/CBFV (CVR index - CVRi).
Transfer function analysis of the recordings was performed in order to asses dynamic cerebral 
autoregulation. Phase diﬀ erences between ABP and CBFV curves were calculated.(10) Also, an 
autoregulatory index (ARI) was calculated by transforming the transfer function data back to the 
time domain with inverse Fourier transformation.(11) Finally, we have calculated a fi ltered ARI, 
which is an ARI calculated after discarding very low frequency data, a known source of consider-
able variability.(12)
Statistics
Mostly, descriptive statistics were used, since our group of patients was small and not all patients 
could perform all experiments.  Since the patients varied in underlying pathology, some statistics 
were calculated for recordings of individuals only, using a t-test. For on-oﬀ  eﬀ ects in the total 




Figure 1 shows a typical example of a recording in a patient with SCS on and oﬀ . No obvious 
changes occurred. Figure 2 shows box plots of all four patients of the most important variables 
(ABP, HR, CBFB of left and right MCA, ScO2 (NIRS) of left and right territories and average left hand 
palm temperature). When comparing the on and oﬀ  recordings per patient, some small statis-
tically signifi cant diﬀ erences could be detected per patient. For the total group of 4 patients a 
repeated measures analysis could not demonstrate signifi cant on-oﬀ  eﬀ ects.
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Temperature
In three subjects (A, C and D) thermographic measurements of the hand palm were done twice 
per subject, one of which failed in subject A. Results are shown in table 2. 
Figure 1: Typical recording in a patient (subject D) during SCS on and oﬀ . Beat-to-beat data is calculated from the 
high frequency recording, using ABP curve for triggering. X-axis in seconds. MABP; mean arterial blood pressure 
(mmHg), HR; heart rate (bpm), MCAL/R; mean blood fl ow velocity in the left/right MCA (cm/s), ScO2L/R; cerebral 
oxygen saturation (%) in left/right territories, Temp; left hand palm temperature (centigrade), ETCO2; end tidal CO2 
concentration (kPa, secondary axis).
Figure 2: Box plots of patients A-D plotting ‘on’ next to ‘oﬀ ’ for each parameter. MABP; mean arterial blood pres-
sure (mmHg), HR; heart rate (bpm), MCAL/R; blood fl ow velocity in the left/right MCA (cm/s), ScO2L/R; cerebral 
oxygen saturation (%) in left/right territories. Boxes show ﬁ rst and third quartile (center is median), whiskers show 
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IHE was performed in 2 patients (A and B), but failed in patient A for technical reasons (unstable 
data, cardiac extrasystoles). The results of patient B are shown in fi gure 3.
 
Valsalva maneuver
Valsalva maneuvers (VM) were performed three times by two subjects (A and B) with SCS on and 
oﬀ . A representing recording is shown in fi gure 4. When comparing the on and oﬀ  measurements 
of these subjects, a raised ABP during the time that SCS was oﬀ  was shown in subject B. All other 
Table 2: mean temperatures (degrees centigrade) of the hand palm in three 
subjects during SCS on and oﬀ .
 A C-1 C-2 D-1 D-2 
On 35,361 35,361 34,962 35,052 34,861 
Off 35,413 34,916 34,774 35,013 34,632 
Diff -0,052 0,445 0,188 0,040 0,229 
p 0,344 <0,001 0,001 0,307 <0,001 
 
Figure 3: Recording of beat-to-beat data of isometric handgrip exercise (right hand) in subject B during 
SCS on and oﬀ . ABP; arterial blood pressure (mmHg), HR; heart rate (bpm), MCAL/R; blood fl ow velocity 
in the left/right MCA (cm/s), NIRSL/R; cerebral oxygen saturation (%) in left/right territories, ETCO2; end 
tidal CO2 concentration (kPa, secondary axis). PIL/R; pulsatility index on left and right side, CVRiL/R; 
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aspects of the ABP and CBFV recordings were nearly identical in all phases of VM. A beat-to-beat 
recording (using ABP as a trigger) is shown in fi gure 5.
 
Figure 4: Example of a high frequency recording of arterial blood pressure and cerebral blood fl ow 
velocities of the left middle cerebral artery in subject B performing a Valsalva maneuver with SCS on 
and oﬀ . Note the several phases of the VM and the fact that the IV peak in CBFV precedes the peak in 
ABP.
Figure 5: Example of a beat-to-beat recording of subject B performing a Valsalva maneuver. ABP; arterial 
blood pressure (mmHg), HR; heart rate (bpm), MCAL/R; blood fl ow velocity in the left/right MCA (cm/s), 
ScO2L/R; cerebral oxygen saturation (%) in left/right territories, CVRR/L; cerebrovascular resistance index 
left/right, PIL/R; pulsatility index left/right. Upper panels: physiological recordings, ScO2 on secondary 





















































































































The VM on-oﬀ  ratio for patient A was 1.28 and 1.26 and for patient B 1.60 and 1.69. We have 
calculated the mean values for each phase of the VM for CBFV in left and right MCA and for ABP 
from three subsequent recordings (table 3). In both patients, peak fl ow velocities in phase IV were 
higher with SCS turned oﬀ . When calculating autoregulatory indices a trend towards a higher 
AI-IV (autoregulatory index based on ratio of phase IV versus phase I (8, 13)) during SCS was 
detected in subject B (left 1.11 vs. 1.39, p=0.13; right 1.12 vs. 1.37, p=0.07), but not in subject A 
(left 1.25 vs. 1.35, p=0.81; right 1.22 vs. 1.38, p=0.45). AI-II (autoregulatory index based on ratio of 
phase II versus phase I (13)) was below 1 in nearly all measurements, without diﬀ erences between 
SCS on and oﬀ .
 
Analysis of dynamic autoregulation
Phases in the low frequency band, in the 0.1 frequency band, as well as ARI and FARI (fi ltered ARI) 
were calculated. Not all coherence was suﬃ  cient to calculate phases; no signifi cant diﬀ erences 
in phase could be shown. ARI was not signifi cantly diﬀ erent between SCS on and oﬀ  (4.6 vs. 5.1, 
p = 0.09). The fi ltered ARI, though, showed a signifi cant lower value when SCS was on versus oﬀ  
(5.6 vs. 6.4, p=0.035).
 
 
 Patient A Patient B 
















 On Off On Off On Off On Off On Off On Off 
I 106,83 103,19 76,47 76,67 106,51 104,86 102,31 90,48 49,38 47,71 48,84 49,47 
IIa 88,94 84,14 57,51 56,50 79,59 76,71 48,32 44,80 31,14 31,21 30,48 32,56 
IIb 89,93 85,89 62,33 61,82 84,11 80,47 57,68 53,37 37,53 39,37 35,19 40,94 
III 67,18 64,28 58,67 57,94 78,48 74,93 47,18 43,80 33,92 35,96 29,16 37,31 
IV 95,49 91,51 75,47 84,89 107,06 113,36 84,12 85,23 56,30 61,03 54,60 64,37 
Table 3: mean values for each VM phase comparing SCS on and oﬀ  (averages from 3 maneuvers). CBFV; cere-
bral blood fl ow velocity, MABP; mean arterial blood pressure.
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Discussion
We have performed several experiments to explore the eﬀ ects of cervical SCS on CBF. No CBF 
changes could be distinguished in a supine resting position (compatible with our results with 
cervical TENS in healthy subjects, chapter 4), but an increased hand temperature was demon-
strated in two out of three patients (patient C and D). This matches the expectation that SCS 
decreases sympathetic tone in eﬀ erent pathways and causes vasodilatation. Subject A failed to 
show a hand temperature rise, but had suﬀ ered a medullary concussion that potentially interferes 
with the eﬀ ects of SCS. Nevertheless, the eﬀ ects as seen in subjects C and D are consistent with 
our hypothesis that cervical SCS can modulate sympathetic pathways. In resting conditions the 
eﬀ ects on the sympathetic fi bers towards the cerebral vasculature are most likely irrelevant in the 
light of other mechanisms that control CBF and therefore no change could be detected.
We hypothesize that sympathetic pathways are of higher importance when CBF is challenged. 
Therefore, we have applied IHE and VM to challenge CBF, in order to detect whether electrical 
modulation aﬀ ected the ability of cerebral autoregulation to cope with these challenges. Both 
IHE and VM are measures that were previously used to challenge CBF and autoregulation. (14-18) 
During the IHE measurements a rise in ABP and HR was noted, while CBFV did not change. An 
increase of contra-lateral ScO2 was shown, demonstrating the added value of NIRS (as compared 
to TCD alone). Apparently the increased distal fl ow did not aﬀ ect CBFV in the middle cerebral 
artery (MCA). When handgrip was released a steep drop in ABP and HR was observed, while CBFV 
only slightly decreased associated with a temporary increase of PI. No obvious diﬀ erences in CBF 
changes between SCS on and oﬀ  were found. The relevance of this PI change is unclear, but an 
increased PI has been observed in other circumstances with increased CBF and decreased CVR, 
such as a reduction in cerebral perfusion pressure. (9, 19)
During VM, some interesting observations were made. Figure 5 shows an example of a beat-
to-beat recording. In phase I ABP and HR rise, whereas CBFV and ScO2 did not change. During 
IIa CBFV dropped only to rise in IIb as a result of autoregulation, while ScO2 decreased. During 
phase III ABP dropped, associated with a slight drop in CBFV and further decreasing ScO2. During 
phase IV there was an apparent overshoot in CBFV while ABP increases, ScO2 only increased a few 
seconds later. The ScO2 curve seemed to lag a few seconds behind the CBFV curve, which can be 
explained by the transit time phenomenon. (20) CVR and PI cannot be interpreted like in other re-
cordings, since VM increases ICP. We have found a lower peak fl ow velocity during phase IV when 
SCS was on, while blood pressures did not diﬀ er. Also AI-IV was higher with SCS switched on. This 
observation suggests that cerebral autoregulation is better capable of coping with the sudden 
increase in ABP during phase IV when SCS is on and seems inconsistent with the theory that SCS 
should attenuate distal vasoconstriction (by decreasing sympathetic tone). Also, when compar-
ing our VM recordings with recordings as presented by others (17) (8), some diﬀ erences become 
apparent (e.g. we found less apparent changes in CBFV during phase II and III and less overshoot 
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in phase IV), suggesting our fi ndings cannot be generalized. This can be caused by the fact that 
we did not measure intrathoracic pressure during VM, so performance can be inconsistent. Also, 
the Valsalva ratio in subject A was borderline, while it was normal in subject B. (21) Finally AI-II was 
lower than 1 in all VMs performed, suggesting attenuated autoregulation. (13)
Analysis of dynamic CA showed decreased autoregulatory capability (lower ARI and FARI) when 
SCS was switched on. This eﬀ ect is comparable to the known eﬀ ects of hypercapnia, associated 
with distal arteriolar vasodilatation and decreased ARI. So possibly the observed eﬀ ects were due 
to distal vasodilatation, which makes it harder for the system to compensate for changes in ABP, 
reducing the ARI. Then again, no eﬀ ects of distal vasodilatation were seen in the ScO2 measure-
ments. It is possible that the diﬀ erent modalities have a diﬀ erent sensitivity for small amounts of 
arteriolar diameter alterations. Also, such distal vasodilatation should be mediated by intrinsic 
sympathetic pathways, but modulation of these intrinsic pathways seems less plausible because 
of the distance of the SCS electrodes to the brainstem nuclei.
Limitations of this study
Several aspects of our experiments potentially aﬀ ect the interpretation of our fi ndings. First, only 
a small number of patients with true cervical SCS was available. Their underlying disease can very 
well have interfered with sympathetic pathways (especially the medullary injury in subject A) and 
with our experiments (amputation, complex regional pain syndromes, or plexus injury), making it 
very challenging to examine the eﬀ ects of cervical SCS on CBF. Second, the position of the elec-
trodes was diﬀ erent in the 4 subjects and we have limited our experiments to the patients’ own 
programmed stimulation parameters (for ethical reasons), which might have had diﬀ erent eﬀ ects 
on sympathetic output. We therefore cannot rule out the possibility of diﬀ erent fi ndings at dif-
ferent stimulation settings. Third, the eﬀ ects of long-term SCS might be diﬀ erent from short-term 




During resting conditions no eﬀ ects of cervical SCS on CBF could be shown, however interesting 
observations were done during CBF challenges and when analyzing dynamic CA, which can be 
of value in future research on subjects with cervical SCS. These include the changes in PI during 
the end of an isometric handgrip exercise, changes in CBFV during VM phase IV and changes in 
dynamic autoregulation indices. We would encourage that these parameters are taken into ac-
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Introduction
This thesis is focused on the modulation of cerebral blood fl ow by cervical electrical stimulation 
and the assumption that the sympathetic nervous system plays a specifi c role as a pathway. We 
had in mind to ultimately perform a prospective randomized trial using electrical nerve stimula-
tion in SAH patients. We were aware of some results with cervical SCS (as summarized elsewhere 
(1)), but chose to focus on TENS because of its non-invasive nature. Instead of only fi nding empir-
ical evidence for TENS treatment in SAH, we were interested to elucidate the fundamental 
physiological eﬀ ects of TENS and SCS on cerebral blood fl ow. Therefore the literature on anatom-
ical aspects of innervation of cerebral vessels was studied, the physiological evidence in humans 
was reviewed (chapter 2), a laboratory environment was created to perform physiological meas-
urements while using TENS or SCS and statistical methods were applied for ad-hoc analysis (chap-
ter 3). These measurements and methods were fi nally applied in three separate studies on small 
groups of subjects (chapters 4, 5 and 6). These studies have provided knowledge on how to study 
the eﬀ ects of electrical stimulation on CBF, on the clinical eﬀ ects of electrical stimulation (re-
garding CBF) and on the feasibility of electrical stimulation in SAH patients.
In this fi nal chapter the results will be summarized, followed by a general discussion and 
suggestions for future research.
Summary
Chapter 2
Until now, an abundance of studies on the subject has failed to bring the defi nitive answer on 
the role of sympathetic pathways in CBF regulation. Several reasons why studies on the relation 
of CBF and sympathetic tone fail to produce unambiguous results were brought forward. When 
reviewing the literature we have tried to overcome these problems by the following selection 
criteria.
Studies on sympathetic pathways and CBF regulation are species dependent. For example 
receptor distribution was shown to diﬀ er among species. Therefore, we only included studies 
in humans.
Huge heterogeneity in methods to determine CBF or CA exists in the literature. Also several 
experimental set-ups that were used in studies on CBF and sympathetic agents often make it 
impossible to separate the eﬀ ect of the agent on the brain from hemodynamic eﬀ ects. When 
reviewing these studies, we strictly selected for methodology and we have selected studies 
that corrected for hemodynamic eﬀ ects.
Often mechanisms that can confound CBF measurements are not corrected for, therefore we 
focused on studies that at least measured CO2.
Human studies often include subjects with diﬀ erent pathologies, which further increases he-







Two other problems seem to contribute to the diﬃ  culty in demonstrating eﬀ ects of sympathetic 
tone on CBF. (1) Eﬀ ects become more obvious when CBF is challenged compared to a resting 
situation (a fact which was hardly appreciated in the early days of ganglionic blockade studies); 
(2) autoregulatory eﬀ ects can be described as static regulation, but also dynamic eﬀ ects can be 
demonstrated, once beat-to-beat registration became possible with the introduction of TCD.
Taking all this into account, it was shown that a surgical excision of all sympathetic outfl ow toward 
cerebral arteries increased CBF, as did chemical blockade. Also, after strict selection of methodol-
ogical sound studies, one can appreciate that especially alpha blocking agents reduce the ability 
of cerebral autoregulation to cope with increases in ABP, suggesting sympathetically-mediated 
vasoconstriction is part of CBF regulation.
Chapter 3
Given the eﬀ ects of sympathetic pathways on CBF, it becomes appealing to fi nd out if one can 
modulate these pathways in order to improve CBF. Since CBF regulation is a complex system of 
several mechanisms that infl uence hemodynamics and cerebral vessel diameter (fi gure 1, chap-
ter 3) a lot of variables have to be taken into account when measuring the eﬀ ects on CBF of any 
intervention. In this chapter we have presented the laboratory set-up that we have been using in 
the experiments as presented in chapters 5 and 6.
This laboratory set-up has been designed in order to be able to detect changes in several aspects 
of the regulatory mechanisms of CBF. Adding measurements of cerebral saturation (with NIRS) 
to blood fl ow velocity measurement (with TCD), facilitates the interpretation of TCD especially 
when the vessel diameter changes, as illustrated in table 1, chapter 3. Also, we included ad-hoc 
statistical analysis using algorithms with eﬀ ect size calculations to facilitate the immediate in-
terpretation of data recordings. Especially in studying electrical modulation this proved to be of 
great help, since several diﬀ erent settings of parameters (frequency, current, and pulse width) 
have to be compared.
In this chapter we have presented our motivation for the use of TENS instead of (e.g.) SCS based 
on the assumptions that eﬀ ects of SCS are indirect (since the spinal sympathetic fi bers are located 
outside of the electrical fi eld), which possibly can be achieved by cutaneous stimulation as well. 
Also TENS has shown analogies to SCS in other applications and TENS is non-invasive.
Chapter 4
In chapter 4 we have described the experiments with cervical TENS in a phase 1 study in healthy 
subjects. The experimental set-up was slightly diﬀ erent from the set-up as described in chapter 3, 
because NIRS was not yet available to us at that time.
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We have shown that cervical TENS is feasible and it can be safely applied in healthy subjects, 
although the maximum tolerated current did vary. No relevant skin irritation was noted. We have 
measured CBF changes in rest and during a hyperventilation challenge. No signifi cant eﬀ ects on 
MCA fl ow velocities of fi ve diﬀ erent frequencies (2, 20, 50, 100 and 120Hz) in a resting situation 
could be demonstrated. The eﬀ ect of hyperventilation (ETCO2 of 2%) on MCA fl ow velocities was 
not diﬀ erent whether TENS was used at 100Hz, or not.
We have concluded based on these results that cervical TENS can be safely applied. It is likely that 
the strong intact CA of these healthy subjects has interfered with small eﬀ ects of TENS in CBF, so 
we hypothesized that results could be diﬀ erent in situations of disturbed CA.
Chapter 5
Planning to perform a larger prospective trial using TENS in SAH patients with vasospasm, a pilot 
study in 10 patients was performed. Using our ad-hoc analysis we found greater eﬀ ect sizes in 
the higher frequencies (100 and 120Hz), so those frequencies were used during the study. Even 
though not all patients could tolerate TENS during the entire experiment, and even though they 
generally had only mildly increased fl ow velocities, we did fi nd some small eﬀ ects on CBFV and 
cerebral saturation. Increases in cerebral saturation were more obvious than changes in cerebral 
blood fl ow velocities. Particularly the non-spastic vessels (according to the Lindegaard criteria) 
seem to contribute to the improved cerebral saturation, which makes one wonder what the 
clinical eﬀ ect of such stimulation could be. Taken into account that ETCO2 increased slightly du-
ring TENS the eﬀ ects on CBFV are probably underestimated while eﬀ ects on ScO2 might be over-
estimated. As there was no control group (pilot study) and this intervention cannot be performed 
in a blinded fashion, bias cannot be ruled out in these experiments.
We encountered that TENS treatment was poorly tolerated by SAH patients, mostly because they 
were restless or agitated, which resulted in dislodging of electrodes. Also, patients found it hard to 
tolerate the paresthesias generated by the TENS. Even though healthy subjects (chapter 4) could 
be easily instructed to tolerate these sensations, SAH patients were frustrated by these non pain-
ful stimuli, possibly because they were already sensitized by the head-ache caused by the SAH. 
For this reason, it is our strong opinion that a prospective randomized controlled trial on TENS in 
SAH patients (and other neurological disorders) would be diﬃ  cult to perform.
Chapter 6
Since our analysis of TENS in SAH patients showed a repeated on-oﬀ  eﬀ ect (not always statistically 
signifi cant), we hypothesize that the concept of a (partial) sympathetic block resulting in de-
creased cerebral vasoconstriction might be correct. Possibly more obvious results can be found 
when the current is applied more closely to the spinal cord, e.g. by cervical SCS, since higher local 
electrical currents can be achieved. A study using SCS in healthy volunteers would not be ethical 
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because of the invasive nature of the procedure. Therefore we have selected patients who were 
treated with cervical SCS for non-related causes (neuropathic pain). In these patients we have 
performed several experiments using the set-up as described in chapter 3. Diﬀ erent challenges 
have been used to fi nd out whether SCS aﬀ ects the way autoregulation copes with changes in 
ABP.
No changes in CBFV and ScO2 parameters were found during rest. A slight increase of hand palm 
temperature was detected, though, in two subjects. This suggests that eﬀ erent sympathetic fi bers 
are indeed partly blocked by cervical SCS, resulting in vasodilatation in the hand. Even though 
some interesting observations were done during the Valsalva maneuver and isometric handgrip 
challenge, no conclusions could be drawn because of the small group of subjects, heterogene-
ous stimulation parameters and diﬀ erent pathologies. When calculating a fi ltered autoregulation 
index (FARI), which discards very low frequency data, a statistically signifi cant decrease in dynamic 
autoregulation was shown when cervical SCS was on. This might be the result of distal vasodila-
tation (as is also seen during hypercapnia), which can increase CBF, but decreased the capacity to 
react to blood pressure changes.
 
Discussion
Several questions have to be addressed in order to ascertain whether or not electrical stimulation 
can result in changes in CBF through sympathetic pathways. First it has to be shown whether the 
sympathetic fi bers innervating cerebral vessels play a role in CBF regulation in humans at all. As 
shown in chapter 2, this has been confi rmed. We have shown that research on the role of sympa-
thetic innervation of cerebral vessels has been hampered by the fact that humans are not always 
comparable to animals and that CBF regulation in part depends on the pathology involved. Also 
the complexity of the combination and interaction of several processes that together result in 
the mechanism that we call cerebral autoregulation, hampers the study of specifi c pathways. For 
example, it can be hard to exclude the eﬀ ects of certain agents on the cerebral blood vessels from 
systemic hemodynamic eﬀ ects.
The second question is whether electrical stimulation is able to modulate sympathetic pathways. 
We did not fi nd any eﬀ ects of TENS on CBF in healthy subjects as demonstrated in chapter 4. We 
have demonstrated in chapter 5 that probably the eﬀ ects of TENS on CBF are either small or non-
existent in SAH patients. Even the highest detected changes seem to fall within the normal vari-
ability between subjects and be of no clinical importance. We were unable to address the same 
question considering SCS in patients, but the measurements in subjects with SCS for neuropathic 
pain, showed no eﬀ ects on CBF in resting conditions. The eﬀ ect of cervical SCS on hand tempera-
ture, though, does suggest a decreased sympathetic tone as a result of SCS.
The third question is whether electrical stimulation is at all feasible in patients. In chapter 5 we 
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have shown that at least in SAH patients TENS does not seem to be a feasible treatment. We are 
aware of other groups that have tried SCS in patients with cerebral low-perfusion states, as de-
scribed elsewhere. (1) Except for the known complications (electrode dislodgement, infection, 
etc) no feasibility problems have been reported.
The fourth question is whether, when electrical modulation has been shown to aﬀ ect CBF 
(whether via sympathetic pathways or not), it can result in clinically relevant outcome changes. 
This is a question we have not yet addressed, but recommendations concerning experimental 
set-ups can be done based on our experiences.
Before recommendations for future studies will be made, some physiological, clinical and experi-
mental observations will be highlighted.
Physiological  ndings
A schematic representation of CBF regulation has been shown in fi gure 1, chapter 3. We have 
shown that dynamic as well as static autoregulation is in part dependent on sympathetic tone. 
It remains uncertain whether intrinsic sympathetic pathways play a role in CBF regulation in hu-
mans, because this is hard to study. Extrinsic pathways do play a role, as was demonstrated by 
ganglionectomy studies. Most of the studies addressing this subject lack the proper method-
ology to demonstrate the role of sympathetic pathways in CBF regulation (as discussed in chapter 
2), but also the diﬀ erences in species are accountable, since animal studies generated confl icting 
results. Possibly the volume of our brain and the fact that we walk upright might have triggered 
a human-specifi c evolution of cerebral autoregulation.
Whether electrical stimulation has eﬀ ect through the intrinsic or extrinsic system is uncertain, but 
eﬀ ects through the extrinsic system seem more plausible, considering the results of ganglionec-
tomies and the distance of electrical stimulation sites to sympathetic pathways. Research on the 
role of parasympathetic pathways in relation to CBF in humans is extremely scarce. Even though 
some studies are available on vagus nerve stimulation (VNS), most measure only local CBF and 
don’t adhere to the selection criteria as defi ned in chapter 2. One study measured CBFV during 
VNS and found no eﬀ ects (2). Animal studies also suggest that the parasympathetic system does 
not play a signifi cant role in cerebral autoregulation. (3)
There is some evidence for involvement of trigeminal pathways in CBF regulation in humans, as 
already mentioned in chapter 1. Ablation of the trigeminal ganglion (in patients with trigeminal 
neuralgia) increased CBF in two studies.(4-5) Another showed decreased fl ow velocities in the 
MCA as a result of electrical stimulation of the trigeminal ganglion, which could mean either a 
decreased CBF or dilatation of MCA.(6) Involvement of sensory trigeminal pathways in CBF regu-
lation seems consistent with animal research and with the fact that cerebral vessels, pial vessels 
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and venous sinuses are innervated by fi bers originating from the ophthalmic division of the tri-
geminal ganglion.(3, 7) The trigemino-cardiac refl ex (TCR) is partially sympathetically mediated, 
which suggests a connection between trigeminal aﬀ erents and sympathetic eﬀ erents. Possibly, 
part of the TCR has a role in regulation of CBF.
Combining the eﬀ ects of sympathetic pathways on CBF with the previous knowledge of trigemi-
nal involvement, a hypothetical model of a “trigemino-sympathetic arc” can be postulated. This 
would involve sensory input from trigeminal fi bers, and sympathetic output towards the cere-
bral vessels via the cervical ganglia (fi gure 1). Sensory input from the ophthalmic branch of the 
trigeminal nerve relays in the trigeminal ganglion and enters the brainstem into the trigeminal 
nucleus. Outfl ow from the caudal part of the trigeminal nucleus towards the superfi cial medullary 
dorsal horn has been suggested, but connectivity with the sympathetic fi bers is yet unknown. (8) 
Outfl ow from the dorsal brainstem could modulate the intermediolateral nucleus of the spinal 
cord. The sympathetic preganglionic cells from this nucleus project towards the inferior and su-
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Figure 1: Schematic representation of sympathetic (green) and trigeminal 
(blue) pathways involved in CBF regulation. Since stimulation of trigeminal 
ﬁ bers can result in autonomic responses (like the trigemino-cardial refl ex), 
we postulate that not only eﬀ erent trigeminal ﬁ bers have a role in CBF regu-
lation. Trigeminal aﬀ erents might also relay in the caudal trigeminal nucleus 
to neurons that connect towards the sympathetic system, resulting in a “trige-
mino-sympathetic arc” of CBF regulation. GG; trigeminal ganglion of Gasser, 
HT; hypothalamus, ICA; internal carotid artery, ILT; intermediolateral tract of 
the spinal cord, TN; trigeminal nucleus, TNc; trigeminal caudal nucleus, SCG; 













Clinical and experimental considerations
The fact that circulating sympathetic agents, especially those acting through alpha-receptors, 
do aﬀ ect CBF has implications for anesthesiologists, neurologists and other doctors who treat 
patients with cerebral ischemic disease. This does not only include SAH patients, but all patients 
with stroke; the application of alpha agonists like phenylephrine could result in decreased cere-
bral perfusion and ischemia. Specifi cally in treating delayed cerebral ischemia in SAH, one has 
to reconsider the use of alpha agonists in order to increase the mean arterial pressure; its eﬀ ects 
on cerebral vessels could have counterproductive results. On the other hand, possibly alpha-
antagonists could result in cerebral vasodilatation and increased CBF, especially when combined 
with measures to increase cardiac output.
Even though TENS was shown to be safe in healthy subjects and in SAH patients and some small 
changes in ScO2 and CBFV were suggested by our data, TENS is not suitable to be used in clinical 
studies, since patients did not tolerate the paresthesias. Our observations concerning the eﬀ ects 
of cervical SCS on CBF are not very convincing either. We have shown, though, that certain chal-
lenges and calculations on dynamic CA can be especially useful in determining eﬀ ects. Possi-
bly SCS can have more important eﬀ ects on CBF in SAH patients, whose other vasoregulatory 
mechanisms are attenuated.
Our (somewhat disappointing) results should not refrain others from studying SCS to improve 
CBF, since eﬀ ects have been demonstrated in other studies.(1) Physical characteristics of SCS like 
higher electrical fi eld, closer location to the spinal cord and less cutaneous irritation, could result 
in more eﬀ ects on CBF. In order to better elucidate the mechanisms and in order to better detect 
the eﬀ ects of SCS, it is suggested to only apply SCS for CBF modulation in clinical studies that 
include extensive physiological testing, like in our set-up as described in chapter 3. The set-up 
should include methods to assess CBF, preferably by methods with great spatial and temporal 
resolution. Since no method, as for now, provides these resolutions at the same time, the com-
bination of TCD with NIRS can provide a real-time indirect estimate of CBF changes. Methods 
like perfusion computed tomography, BOLD MRI or arterial spin labeling MRI can provide more 
spatial detail. Whenever possible, challenges should be applied in order to assess the ability of the 
cerebral vasculature to adapt to ABP rises or drops. As we have shown, possibly VM and IHE can 
give important clues when comparing these challenges at several time-points before and during 
an intervention. Also assessment of dynamic CA could be included in future experiments, since 
these possibly detect changes in reactivity that would be unnoticed when only static CA would 
be studied.
Suggestions for future research
More studies on TENS in SAH patients are not warranted based on our results. Possibly subcutane-
ous electrical nerve stimulation (SENS) could overcome some problems of dislodging electrodes. 
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Summary and general discussion
Still SAH or stroke patients might be easily frustrated by the paresthesias generated, depending 
on the severity of the disease.
It would be wise to choose candidates for electrical modulation of CBF by assessing several 
aspects of cerebral autoregulation before start of the study. Possibly only patients with disturbed 
static or dynamic CA will profi t from electrical modulation. The inclusion of only severely ill pa-
tients can be considered because: (1) probably more severe defects in CA (or vasospasm) will be 
found, (2) changes in CBF can be more easily detected, (3) more invasive procedures (like SCS) are 
warranted as prognosis is poor and (4) they are less likely to be troubled by the generated pares-
thesias. Drawbacks of only including severely ill patients are; (1) they cannot be instructed to per-
form challenges like IHE, (2) possibly unsuspected and previously not detected serious adverse 
events might occur, (3) informed consent has to be by proxy and (4) stricter inclusion criteria will 
result in a longer duration of the study.
Ganglionectomy or selective sympathectomy might be considered in severely ill patients with 
vasospasm after SAH, as has been tried before with some success.(9) Especially when more ex-
tensive physiological testing is applied to better illustrate the eﬀ ects, this might lead to further 
understanding of the mechanisms involved.
Animal research on the eﬀ ects of trigeminal pathways on CBF has been focused on the eﬀ er-
ent system. We have suggested an aﬀ erent link between trigeminal and sympathetic neurons in 
CBF regulation. Future research could explore if such pathway exists and whether it could be of 
therapeutic importance. For example it would be interesting to fi nd out whether the eﬀ ects of 
trigeminal stimulation on CBF can be blocked by a sympathetic ganglion block.
In conclusion, even though exact pathways remain unknown, the notion that sympathetic 
pathways are involved in CBF regulation has been confi rmed. Clinical eﬀ ects of electrical 
modulation on CBF regulation remain unconvincing, but electrical stimulation is capable of some 
modulation of sympathetic outfl ow. Finally, this thesis has provided insights in the experimental 
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Samenvatting en algemene discussie
Introductie
Dit proefschrift behandelt de modulatie van de cerebrale doorbloeding (cerebral blood fl ow, 
CBF) door cervicale elektrische stimulatie en de aanname dat het sympathisch zenuwstelsel hier-
in een specifi eke rol speelt. Oorspronkelijk waren we met onze onderzoeksgroep van plan een 
prospectieve gerandomiseerde studie uit te voeren met elektrische zenuwstimulatie in patiënten 
met een SAB (subarachnoïdale bloeding). Enkele resultaten met cervicale ruggenmergsstimulatie 
(spinal cord stimulation, SCS) waren ons bekend (zoals elders samengevat (1)), maar we hebben 
ervoor gekozen ons te richten op transcutane elektrische neurostimulatie (TENS) omdat dit niet 
invasief is. Behalve alleen empirische bewijs te willen vinden voor TENS behandeling bij patiënten 
met een SAB, wilden we ook meer kennis vergaren over de fundamentele fysiologische eﬀ ecten 
van TENS en SCS op CBF. Daarom is de literatuur bestudeerd over de anatomische aspecten van 
innervatie van cerebrale vaten, is het fysiologische bewijs voor de rol van de sympathicus in CBF 
regulatie verzameld (hoofdstuk 2), is een laboratoriumopstelling gecreëerd om fysiologische me-
tingen te kunnen verrichten tijdens het gebruik van TENS of SCS en zijn statistische methodes 
toegepast voor ad hoc analyse (hoofdstuk 3). Deze metingen en methoden zijn vervolgens toe-
gepast in drie afzonderlijke studies met kleine groepen vrijwilligers en patiënten (hoofdstukken 
4, 5 en 6). Deze studies geven inzicht in hoe de eﬀ ecten van elektrische stimulatie op CBF bestu-
deerd kunnen worden, in de klinische eﬀ ecten van elektrische stimulatie (wat betreft CBF) en in 
de toepasbaarheid van elektrische stimulatie bij SAB patiënten.
In dit laatste hoofdstuk worden de resultaten samengevat, gevolgd door een algemene discussie 
en suggesties voor toekomstig onderzoek.
Samenvatting
Hoofdstuk 2
Voorheen is een veelheid aan studies niet in staat gebleken defi nitief antwoord te geven op de 
vraag wat de rol is van de sympathische banen in CBF regulatie. Verscheidene redenen waarom 
studies over de relatie tussen CBF en sympathische tonus niet in staat waren ondubbelzinnige re-
sultaten te boeken zijn beschreven. Bij het beoordelen van de literatuur hebben we geprobeerd 
deze problemen te omzeilen middels de volgende selectiecriteria.
Studies over sympathische banen en CBF regulatie zijn soort afhankelijk. De receptor distri-
butie is bijvoorbeeld verschillend tussen soorten. Daarom hebben we alleen humane studies 
geïncludeerd.
Er bestaat een enorme heterogeniteit in de literatuur wat betreft methoden om CBF of cere-
brale autoregulatie (CA) te beoordelen. Tevens maken diverse experimentele opstellingen, die 
worden gebruikt in studies naar CBF en sympathisch werkende middelen, het onmogelijk om 
de eﬀ ecten van het middel op het brein te onderscheiden van de hemodynamische eﬀ ecten. 





en hebben we alleen studies geïncludeerd die corrigeren voor hemodynamische eﬀ ecten.
Vaak wordt niet gecorrigeerd voor mechanismen die de CBF metingen kunnen vertroebelen, 
daarom hebben we ons gericht op studies die op zijn minst CO2 meten.
Humane studies includeren vaak patiënten met verscheidene aandoeningen, hetgeen de he-
terogeniteit verder doet toenemen. Dat is de reden dat we ons gericht hebben op onderzoe-
ken met gezonde vrijwilligers.
Twee andere problemen lijken bij te dragen aan de moeilijkheid van het aantonen van eﬀ ecten 
van sympathische tonus op CBF. (1) Eﬀ ecten worden duidelijker wanneer de handhaving van 
de cerebrale doorbloeding onder druk komt te staan, vergeleken met een rustsituatie (iets wat 
nauwelijks erkend werd in de tijd van de studies met ganglion blokkades); (2) autoregulatoire 
eﬀ ecten kunnen worden beschreven als statische processen, maar sinds ‘beat-to-beat’ registratie 
mogelijk werd met de introductie van transcraniële Doppler sonografi e (TCD), ook als dynami-
sche eﬀ ecten.
Dit alles meewegend, hebben we aangetoond dat chirurgische excisie van alle sympathische in-
nervatie van de cerebrale arteriën CBF verhoogde, net als een chemische blokkade. Ook kunnen 
we, na strikte selectie voor methodologisch correcte studies, inzien dat met name alfareceptor 
blokkerende middelen het vermogen van de cerebrale autoregulatie om bloeddrukstijgingen te 
compenseren verminderen. Dit is een aanwijzing dat sympathisch gemedieerde vasoconstrictie 
een onderdeel uitmaakt van de CBF regulatie.
Hoofdstuk 3
Wanneer we ons realiseren dat de sympathische banen CBF beïnvloeden, wordt het aantrekkelijk 
om uit te vinden of deze banen te moduleren zijn met als doel CBF te verbeteren. Aangezien CBF 
regulatie een complex systeem van verscheidene mechanismen omvat die de hemodynamiek 
en cerebrale vaatdiameter beïnvloeden (fi guur 1, hoofdstuk 3), zijn er vele variabelen waar reke-
ning mee dient te worden gehouden wanneer de eﬀ ecten van een interventie op CBF worden 
gemeten. In dit hoofdstuk beschrijven we onze laboratoriumopstelling die we hebben gebruikt 
in de experimenten zoals beschreven in hoofdstukken 5 en 6.
Onze opstelling is ontworpen met als doel veranderingen in verscheidene aspecten van de re-
gulatoire mechanismen van CBF te detecteren.  Door metingen van cerebrale saturatie (middels 
‘near-infrared spectroscopy’, NIRS) toe te voegen aan metingen van bloedstroomsnelheden (met 
TCD), wordt de interpretatie vereenvoudigd, vooral wanneer de vaatdiameter veranderd, zoals 
geïllustreerd in tabel 1 van dit hoofdstuk. Tevens hebben we ad hoc statistische analyse toe-
gepast met gebruikmaking van algoritmen met eﬀ ectgrootte berekeningen om onmiddellijke 
interpretatie van de registraties mogelijk te maken. Vooral bij het bestuderen van de eﬀ ecten van 
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tie, stroom, pulsbreedte) kunnen worden vergeleken.
We beschrijven in dit hoofdstuk ook de motivatie om TENS te gebruiken in plaats van (bijvoor-
beeld) SCS, gebaseerd op de aanname dat de eﬀ ecten van SCS indirect zijn (aangezien de spinale 
sympathische banen buiten het opgewekte elektrische veld liggen), welke mogelijk ook door 
cutane stimulatie kunnen worden bereikt. Bovendien heeft TENS analogieën laten zien met SCS 
in andere applicaties en is het niet invasief.
Hoofdstuk 4
In hoofdstuk 4 hebben we de experimenten beschreven met cervicale TENS in een fase 1 studie 
met gezonde proefpersonen. De experimentele opstelling was iets anders dan degene die werd 
beschreven in hoofdstuk 3, aangezien we nog niet de beschikking hadden over NIRS.
We toonden aan dat cervicale TENS toepasbaar is en dat het veilig kan worden gebruikt bij gezon-
de vrijwilligers, alhoewel de maximaal getolereerde stroom varieerde van persoon tot persoon. 
We zagen geen noemenswaardige huidirritatie. We hebben CBF veranderingen gemeten in rust 
en tijdens hyperventilatie. We konden, in rust, geen signifi cante eﬀ ecten op stroomsnelheden 
in de arteria cerebri media (MCA) aantonen bij vijf verschillende frequenties (2, 20, 50, 100 en 
120Hz). De eﬀ ecten van hyperventilatie (uitademings CO2 (ETCO2) van 2%) op stroomsnelheden 
in de MCA waren niet anders wanneer TENS op 100Hz werd gebruikt, of niet.
Gebaseerd op deze resultaten, hebben we geconcludeerd dat cervicale TENS veilig kan worden 
toegepast. Het is aannemelijk dat de sterke, intacte autoregulatie van deze gezonde vrijwilligers 
geïnterfereerd heeft met de kleine eﬀ ecten van TENS op CBF, dus we postuleerden dat de resulta-
ten anders zouden kunnen zijn in omstandigheden van verstoorde autoregulatie.
Hoofdstuk 5
Omdat we van plan waren een grotere prospectieve studie op te zetten naar TENS in SAB pa-
tiënten met vaatspasmen, werd een ‘pilot’- studie verricht in 10 patiënten. Met behulp van onze 
ad hoc analyse vonden we grotere eﬀ ectgroottes bij hogere frequenties (100 en 120Hz), dus dit 
zijn de frequenties die tijdens de studie werden gebruikt. Alhoewel niet alle patiënten de TENS 
konden verdragen gedurende het hele experiment, en ondanks dat ze over het algemeen slechts 
matig verhoogde stroomsnelheden hadden, vonden we enkele kleine eﬀ ecten op cerebrale 
bloedstroomsnelheden (CBFV) en cerebrale zuurstofsaturatie. De toenames in cerebrale saturatie 
waren evidenter dan de veranderingen in stroomsnelheden. Vooral de niet-spastische vaten (Lin-
degaard criteria) lijken bij te dragen aan de toegenomen cerebrale saturatie, iets wat te denken 
geeft wat betreft de klinische eﬀ ecten van dergelijke stimulatie. Als we in ogenschouw nemen 
dat ETCO2 licht toenam tijdens TENS, dan zijn de eﬀ ecten op de CBFV waarschijnlijk onderschat, 
terwijl de eﬀ ecten op de saturatie mogelijk zijn overschat. Aangezien we geen controle groep 
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hadden (het betrof een pilot) en omdat deze interventie niet geblindeerd kan worden toegepast, 
kunnen we niet elke vorm van bias uitsluiten bij deze experimenten.
We werden geconfronteerd met het feit dat TENS in SAB patiënten slecht werd getolereerd, 
meestal omdat ze rusteloos of geagiteerd waren wat resulteerde in het losraken van de elektro-
den. Ook vonden patiënten het moeilijk de tintelingen die TENS opwekt te verdragen. Ondanks 
dat gezonde vrijwilligers (hoofdstuk 4) makkelijk te overtuigen waren deze tintelingen te accep-
teren, tolereerden SAB patiënten deze niet-pijnlijke stimuli niet, mogelijk omdat ze reeds overge-
voelig waren door de hoofdpijn als gevolg van de subarachnoïdale bloeding. We zijn daarom van 
mening dat een prospectieve gerandomiseerd gecontroleerde studie met TENS in SAB patiënten 
(of andere patiënten met neurologische aandoeningen), zeer moeilijk uitvoerbaar zal zijn.
Hoofdstuk 6
Aangezien onze analyse van TENS bij SAB patiënten een herhaaldelijk aan-uit eﬀ ect liet zien (al-
hoewel niet altijd statistisch signifi cant), denken we dat het concept van een (partieel) sympa-
thisch blok wat leidt tot meer cerebrale vasoconstrictie correct zou kunnen zijn. Mogelijk kun-
nen evidentere eﬀ ecten behaald worden wanneer de stroom dichter bij het ruggenmerg wordt 
toegepast, bijvoorbeeld door cervicale SCS, aangezien hogere lokale elektrische stroomsterktes 
bereikt kunnen worden. Een studie met SCS in gezonde vrijwilligers zal ethisch onaanvaardbaar 
zijn vanwege de invasieve aard van de procedure. Daarom hebben we patiënten geselecteerd 
die al met cervicale SCS werden behandeld voor andere indicaties (neuropathische pijn). Bij deze 
patiënten hebben we verscheidene experimenten uitgevoerd met de opstelling zoals beschre-
ven in hoofdstuk 3. Verschillende tests zijn gebruikt om uit te vinden of SCS van invloed is op de 
manier waarop autoregulatie kan reageren op veranderingen in de bloeddruk.
In rust werden geen veranderingen in CBFV en cerebrale zuurstofsaturatie gevonden. Een ge-
ringe toename van handpalm temperatuur werd gevonden in twee vrijwilligers. Dit is suggestief 
voor een blokkade van eﬀ erente sympathische vezels, resulterend in vasodilatatie in de hand. 
Alhoewel een aantal interessante observaties werd gedaan tijdens de Valsalva manoeuvre en 
isometrische handgrip test, konden er geen conclusies worden getrokken vanwege de kleine 
groep vrijwilligers, inhomogene stimulatie parameters en verschillende ziektes.  Een gefi lterde 
autoregulatie index (FARI, waarbij ultra lage frequentie data wordt verworpen) toonde wel een 
statistisch signifi cante afname in dynamische autoregulatie wanneer cervicale SCS aan stond. Dit 
kan het resultaat zijn van distale vasodilatatie (zoals ook gezien wordt bij hypercapnie), waarbij de 
CBF toeneemt, maar de mogelijkheid om op bloeddrukveranderingen te reageren afneemt.
Discussie
Verscheidene vragen moeten worden beantwoord wanneer men wil vaststellen of elektrische 
stimulatie veranderingen in CBF kan bereiken via sympathische banen. Allereerst moet er worden 
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aangetoond of sympathische banen die de cerebrale bloedvaten innerveren überhaupt een rol 
spelen in de regulatie van CBF in mensen. Zoals beschreven in hoofdstuk 2, is dit bevestigd. We 
beschreven dat onderzoek naar de rol van sympathische innervatie van cerebrale bloedvaten 
gehinderd werd door het feit dat mensen niet altijd vergelijkbaar zijn met proefdieren en dat CBF 
regulatie beïnvloed wordt door de betrokken ziekte of aandoeding. Ook worden de mogelijkhe-
den  tot  onderzoek van specifi eke banen beperkt door de complexiteit van de combinatie en 
interactie van verscheidene processen die tezamen resulteren in het mechanisme dat we cere-
brale autoregulatie noemen. Het is bijvoorbeeld lastig om eﬀ ecten van bepaalde middelen op 
cerebrale bloedvaten te onderscheiden van de systemische hemodynamische eﬀ ecten van die 
middelen.
De tweede vraag is of elektrische stimulatie in staat is sympathische banen te beïnvloeden. We 
hebben geen eﬀ ecten van TENS op CBF gevonden bij gezonde vrijwilligers, zoals aangetoond 
in hoofdstuk 4. In hoofdstuk 5 hebben we aangetoond dat, bij SAB patiënten, waarschijnlijk de 
eﬀ ecten van TENS op CBF erg klein of niet bestaand zijn. Zelfs de hoogst gedetecteerde verande-
ringen lijken binnen de normale variabiliteit tussen proefpersonen te vallen en zijn dus van geen 
klinische waarde. We konden dezelfde vraag niet onderzoeken met SCS in patiënten, maar de 
metingen bij vrijwilligers met SCS voor neuropathische pijn, toonden geen eﬀ ect op CBF in rust. 
De eﬀ ecten van SCS op handpalmtemperatuur, echter, suggereren wel een afgenomen sympa-
thische tonus als gevolg van SCS.
De derde vraag is of elektrische stimulatie toepasbaar is bij patiënten. In hoofdstuk 5 hebben we 
beschreven dat bij SAB patiënten TENS geen goed toepasbare behandeling lijkt. We weten dat 
andere studiegroepen SCS hebben toegepast bij patiënten met verminderde cerebrale door-
bloeding, zoals elders beschreven.(1) Behalve de bekende complicaties (verplaatsing electrodes, 
infectie, e.d.) werden door hen geen toepasbaarheids problemen gerapporteerd.
De vierde vraag is of, als van elektrische modulatie is aangetoond dat het de CBF beïnvloed (via 
sympathische banen of niet), het kan leiden tot klinisch relevante veranderingen in prognose. 
Dit is een onderwerp dat we nog niet hebben bestudeerd, maar aanbevelingen wat betreft de 
experimentele opstelling kunnen worden gedaan op basis van onze ervaringen.
Voordat we op de aanbevelingen voor toekomstig onderzoek komen, willen we eerst nog enkele 
fysiologische, klinische en experimentele observaties benadrukken.
Fysiologische bevindingen
In fi guur 1, hoofdstuk 3 is een schematische weergave gegeven van CBF regulatie. We hebben 
aangetoond dat zowel dynamische als statische autoregulatie deels afhankelijk zijn van sympa-
thische tonus. Het blijft onduidelijk of intrinsieke banen ook een rol spelen in CBF regulatie bij 
mensen, aangezien dit erg moeilijk te bestuderen is. Extrinsieke banen spelen weldegelijk een 
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rol, zoals aangetoond met ganglionectomie studies. Veel studies gebruiken niet de juiste me-
thodologie om de rol van sympathische banen in CBF regulatie aan te tonen (zoals besproken 
in hoofdstuk 2), maar ook de verschillen tussen soorten zijn verantwoordelijk, aangezien dierstu-
dies confl icterende uitkomsten opleveren. Mogelijk dat het volume van ons brein en het feit dat 
we rechtop lopen een humaan-specifi eke evolutie van cerebrale autoregulatie heeft teweeg-
gebracht.
Of elektrische stimulatie eﬀ ect heeft via het intrinsieke of extrinsieke systeem is onzeker, maar 
eﬀ ecten via het extrinsieke systeem lijken plausibeler, gezien de resultaten van ganglion excisies 
en de afstand van de locaties van elektrische stimulatie tot sympathische banen. Er is zeer weinig 
onderzoek gedaan naar de rol van parasympathische banen in relatie tot CBF in mensen. Er zijn 
enkele studies beschikbaar over nervus vagus stimulatie (VNS), maar de meesten meten alleen 
lokale CBF en houden zich niet aan de selectiecriteria die we in hoofdstuk 2 hebben gedefi nieerd. 
Een studie meet cerebrale bloed stroomsnelheden tijdens VNS en vond geen eﬀ ect.(2) Ook dier-
studies suggereren dat het parasympathisch systeem geen signifi cante rol speelt in de cerebrale 
autoregulatie. (3)
Er zijn wel aanwijzingen dat trigeminale banen een rol spelen bij de regulatie van CBF bij mensen, 
zoals reeds aangestipt in hoofdstuk 1. Ablatie van het ganglion trigeminale (bij patiënten met 
trigeminusneuralgie) deed de CBF toenemen in twee studies.(4-5) Een ander onderzoek toonde 
afgenomen stroomsnelheden in de arteria cerebri media (MCA) als gevolg van elektrische stimu-
latie van het ganglion trigeminale, wat kan betekenen dat er sprake is van een afgenomen CBF 
of dilatatie van de MCA.(6) Betrokkenheid van sensorische trigeminale vezels in CBF regulatie is 
consistent met dierproeven en met het feit dat cerebrale bloedvaten, piale bloedvaten en ve-
neuze sinussen worden geïnnerveerd door vezels die hun oorsprong vinden in de ophtalmische 
divisie van het ganglion trigeminale.(3, 7) De trigemino-cardiale refl ex (TCR) is deels sympathisch 
gemedieerd, hetgeen een connectie suggereert tussen trigeminale aﬀ erenten en sympathische 
eﬀ erenten. Mogelijk dat een deel van de TCR ook een rol speelt in de regulatie van CBF.
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Figuur 1: Schematische representatie van sympathische (groen) en trigemina-
le (blauw) banen die betrokken zijn bij CBF regulatie. Aangezien stimulatie van 
trigeminale vezels kan resulteren in autonome responsen (zoals de trigemino-
cardiale refl ex), postuleren we dat niet alleen eﬀ erente trigeminale vezels een 
rol hebben in CBF regulatie. Trigeminale aﬀ erenten kunnen mogelijk schakelen 
in de caudale nucleus trigeminalis naar neuronen die verbinding hebben met 
het sympathisch systeem, resulterend in een “trigemino-sympathische boog” 
van CBF regulatie. GG; ganglion trigeminale van Gasser, HT; hypothalamus, 
ICA; arteria carotis interna; ILT; tractus intermediolaterale van het ruggenmerg, 
TN; nucleus trigeminalis, TNc; caudale nucleus trigeminalis, SCG; ganglion cer-













Als we de eﬀ ecten van sympathische banen combineren met de kennis over trigeminale betrok-
kenheid, kan een hypothetisch model van een “trigemino-sympathische boog” worden gepostu-
leerd. Deze zou dan bestaan uit sensorische input van trigeminale vezels en sympathische output 
naar de cerebrale bloedvaten via de cervicale ganglia (fi guur 1). Sensorische input van de ophtal-
mische tak van de nervus trigeminus schakelt in het ganglion trigeminale en komt de hersenstam 
binnen in de nucleus trigeminalis. Connecties van het caudale deel van de nucleus trigeminalis 
met het oppervlakkige deel van de spinale achterhoorn zijn geopperd, maar de connectiviteit 
met sympathische vezels is onduidelijk.(8) Signalen vanaf de dorsale hersenstam zouden de inter-
mediolaterale nucleus van het ruggenmerg kunnen beïnvloeden. De sympathische pre-ganglio-
naire cellen van deze nucleus projecteren naar het ganglion cervicale superior en inferior, welke 
op hun beurt de sympathische output naar de cerebrale bloedvaten genereren.
Klinische en experimentele overwegingen
Het feit dat circulerende sympathische agentia, in het bijzonder degene die via alfa-receptoren 
hun eﬀ ect uitoefenen, CBF kunnen beïnvloeden, heeft implicaties voor anesthesiologen, neuro-
logen en andere artsen die patiënten met cerebrale ischemie behandelen. Dit betreft niet alleen 
SAB patiënten, maar alle ‘stroke’-patiënten; het toepassen van alfa-agonisten zoals fenylefrine kan 
resulteren in  afgenomen cerebrale doorbloeding en ischemie. Specifi ek bij SAB-patiënten met 
vaatspasmen of ‘delayed cerebral ischemia’ moet het gebruik van medicijnen met een alfa-re-
ceptor-agonistische werking om de bloeddruk te verhogen worden heroverwogen; het eﬀ ect 
van deze middelen op de cerebrale doorbloeding zou onwenselijk kunnen zijn. Aan de andere 
kant, zouden alfa-antagonisten kunnen resulteren in cerebrale vasodilatatie en toegenomen CBF, 
vooral wanneer gecombineerd met maatregelen die de cardiale output verhogen.
Alhoewel TENS veilig bleek bij gezonde vrijwilligers en SAB patiënten, en alhoewel enkele klei-
ne veranderingen in cerebrale saturatie en bloedstroomsnelheden werden gezien, is TENS niet 
geschikt gebleken voor gebruik in klinische studies, aangezien patiënten de paresthesieën niet 
konden verdragen. Onze observaties wat betreft de eﬀ ecten van cervicale SCS op CBF zijn ook 
niet erg overtuigend. We toonden wel aan dat bepaalde tests en berekeningen van dynamische 
autoregulatie in het bijzonder bruikbaar kunnen zijn om eﬀ ecten te bepalen. Mogelijk dat SCS 
meer overtuigende eﬀ ecten heeft op CBF bij SAB patiënten met gestoorde vasoregulatoire me-
chanismen.
Onze (enigszins teleurstellende) resultaten moeten anderen er niet van weerhouden SCS te be-
studeren om CBF te bevorderen, aangezien in andere studies wel eﬀ ecten zijn gezien.(1)  De 
fysische karakteristieken van SCS zoals een sterker elektrisch veld, stimulatie dichter bij het my-
elum en minder cutane irritatie, zouden tot een beter eﬀ ect op de CBF kunnen leiden. Om de 
mechanismen beter te ontrafelen en om de eﬀ ecten van SCS beter te kunnen detecteren, stellen 
we voor SCS alleen toe te passen ten behoeve van CBF modulatie in klinische studies die uitge-
  
Samenvatting en algemene discussie
breide fysiologische tests toepassen, zoals in onze opstelling zoals beschreven in hoofdstuk 3. De 
opstelling zou methodes moeten toepassen om CBF te beoordelen, bij voorkeur met technieken 
met grote spatiele en temporele resolutie. Aangezien geen enkele techniek, vooralsnog, deze 
beide resoluties tegelijk biedt, kan de combinatie van TCD en NIRS een ‘real-time’ schatting geven 
van CBF veranderingen. Methoden als perfusie-CT (computer tomografi e), ‘blood oxygen level 
dependent’ MRI of ‘arterial spin labeling’ MRI kunnen meer ruimtelijk detail leveren.  Indien mo-
gelijk moeten tests worden toegepast om het vermogen van de cerebrale vasculatuur om zich 
aan te passen aan bloeddruk stijgingen of dalingen te bepalen. Zoals we hebben aangetoond, 
kunnen mogelijk de Valsalva manoeuvre en de isometrische handgrip-test belangrijke informatie 
verschaﬀ en wanneer deze tests worden vergeleken op verschillende momenten voor en tijdens 
een interventie. Ook het beoordelen van de dynamische autoregulatie kan worden betrokken in 
toekomstige experimenten, aangezien dit mogelijk veranderingen in reactiviteit kan detecteren 
die niet opgemerkt worden als alleen statische cerebrale autoregulatie wordt bestudeerd.
Suggesties voor verder onderzoek
Meer studies met TENS bij SAB patiënten zijn op basis van onze resultaten niet aan te bevelen. 
Mogelijk dat subcutane elektrische zenuwstimulatie (SENS) problemen van losrakende elektro-
den kan omzeilen. Dan nog kan het zijn dat SAB of ‘stroke’-patiënten snel last zullen hebben van 
de tintelingen, afhankelijk van de ernst van de ziekte.
Het lijkt ons verstandig kandidaten voor elektrische modulatie van CBF te selecteren door diverse 
aspecten van cerebrale autoregulatie te beoordelen, alvorens een studie start. Mogelijk dat al-
leen patiënten met verstoorde statische of dynamische autoregulatie profi teren van elektrische 
modulatie. Het valt te overwegen alleen ernstig zieke patiënten te includeren om de volgende 
redenen: (1) waarschijnlijk zullen ernstigere afwijkingen in CA (of vaatspasme) worden gevonden, 
(2) veranderingen in CBF kunnen makkelijker gedetecteerd worden, (3) bij een slechte prognose 
zijn meer invasieve procedures (zoals SCS) te verdedigen en (4) het is minder waarschijnlijk dat ze 
last zullen hebben van de paresthesieën die worden opgewekt. Nadelen van het includeren van 
alleen ernstig zieke patiënten zijn: (1) ze kunnen geen tests uitvoeren zoals de isometrische hand-
grip-test, (2) mogelijk kunnen onverwachte en eerder niet gedetecteerde ernstige bijwerkingen 
optreden, (3) familieleden zullen toestemming moeten geven en (4) striktere inclusiecriteria zul-
len leiden tot een langere duur van de studie.
Ganglion excisie of selectieve sympathectomie kunnen worden overwogen bij ernstig zieke pa-
tiënten met vaatspasmen na een SAB, zoals eerder gedaan met enig succes.(9) Vooral wanneer 
uitgebreide fysiologische tests worden toegepast om de eﬀ ecten beter te kunnen beoordelen, 
kan dit leiden tot een beter begrip van de mechanismen die betrokken zijn.
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Dierproeven naar de eﬀ ecten van trigeminale banen op CBF zijn gericht geweest op het eﬀ erente 
systeem. Wij hebben een aﬀ erente verbinding tussen trigeminale en sympathische neuronen 
gesuggereerd met betrekking tot CBF regulatie. Toekomstig onderzoek zou kunnen bekijken of 
zulke verbindingen en banen bestaan en of deze van therapeutisch belang zouden kunnen zijn. 
Het zou bijvoorbeeld interessant zijn, te bepalen of de eﬀ ecten van trigeminale stimulatie op CBF 
kunnen worden tenietgedaan met een sympathische ganglionblokkade.
Concluderend, ondanks dat de exacte banen onduidelijk blijven, is bevestigd dat sympathische 
banen een rol spelen in de CBF regulatie bij mensen. Klinische eﬀ ecten van elektrische modulatie 
van CBF regulatie blijven onovertuigend, maar elektrische stimulatie is in staat tot enige modula-
tie van sympathische eﬀ ecten. Tot slot verschaft deze dissertatie inzicht in de experimentele tech-
nieken die van belang kunnen zijn bij toekomstig onderzoek in dit interessante onderzoeksveld.
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Dit proefschrift is af, tijd voor een nieuw project! Maar niet voordat ik mijn dank heb uitgesproken 
voor iedereen die de afgelopen zes jaar heeft bijgedragen aan de totstandkoming hiervan. Al-
lereerst de vrijwilligers, de patiënten en hun families die toestemming gaven deel te nemen aan 
mijn experimenten. Zonder hen was geen experiment mogelijk geweest en was geen letter op 
papier gekomen.
Mijn begeleiders, Prof. dr. Michiel Staal, Dr. Marc van Dijk en Dr. Jan-Willem Elting. Grote dank 
ben ik jullie verschuldigd voor de bevlogen begeleiding, onze inspirerende bijeenkomsten en 
het aanhoudende vertrouwen in een afl oop inclusief proefschrift. Beste Michiel, je vermogen 
overzicht over het geheel te houden, altijd de implicaties voor de kliniek voor ogen te houden 
en verschillende subdisciplines binnen de neurochirurgie en neurologie te verbinden, zijn een 
inspiratie. Beste Marc, je brede kennis, kritische kijk op mijn geschriften en je deur die altijd open 
staat, hebben mij enorm geholpen. Beste Jan-Willem, dankzij jouw enthousiasme en hulp heb-
ben we een lab opstelling op kunnen zetten welke de spil is geworden waarom dit proefschrift 
draait. Je inzicht in de mathematische en fysiologische aspecten van cerebrale autoregulatie was 
zeer inspirerend (alhoewel het vaak boven mijn pet ging) en was essentieel voor de voltooiing 
van dit proefschrift.
Professor Mooij, beste Jan Jakob, jij was degene die me enthousiast heeft gemaakt voor het vak, 
die me toeliet tot de opleiding neurochirurgie, en de eerste stappen op het gebied van de we-
tenschap heeft doen zetten. Onze eerste onderzoeksideeën hebben het dan uiteindelijk niet 
gehaald, toch hebben die ideeën aan de basis gestaan van dit proefschrift. Je had er altijd vertrou-
wen in dat dit onderzoek tot een promotie zou leiden en je hebt gelijk gekregen.
Het is voor mij een grote eer dat professor Absalom, professor Boddeke en professor van Lieshout 
bereid zijn geweest plaats te nemen in de beoordelingscommissie. Ik wil u van harte bedanken 
voor het lezen en beoordelen van mijn proefschrift.
De statistici die hebben bijgedragen aan de artikelen in dit proefschrift ben ik grote dank 
verschuldigd. Berry Middel, Vaclav Fidler en Roy Stewart, jullie hebben mij bijgestaan bij de vaak 
complexe analyses; wanneer ik aan de grote bergen data geen zinnige vorm kon geven, wisten 
jullie orde in de chaos te brengen, verbanden te leggen en een en ander te reduceren tot begrij-
pelijke conclusies.
Stafl eden neurochirurgie van het UMCG, naast al genoemde Jan Jacob, Michiel S. en Marc, ook 
Rob, Eelco, Jan, Maarten, Jos en  Michiel W., jullie hebben me niet alleen gestimuleerd me weten-
schappelijk te ontwikkelen, maar in hetzelfde tijdsbestek de mogelijkheid gezien mij op te leiden 
tot neurochirurg. Aan jullie heb ik mij gespiegeld, alles wat ik kan en ken als neurochirurg, heb ik 
aan jullie te danken.
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Paranimfen Clemens en Michiel. Ter Borch in Zuidlaren, Bankastraat en nu Broerplein in 
Groningen, belangrijke zaken doen we samen. Hopelijk is er na deze promotie weer meer tijd 
voor samen lopen, kamperen, schaken, catan, risk… Michiel, het spijt me dat ik je heb vermoeid 
met deze zware kost, het is een eer dat jij me als broer en paranimf bijstaat tijdens de verdediging. 
Clemens dank voor je kritische vragen en de vele ‘wetenschappelijke’ discussies die we o.a. op de 
fi ets naar het UMCG voerden. Met jou als paranimf heb ik een goede hulplijn.
Pap, mam, ik ben blij dat het af is. Het doorzettingsvermogen en kritisch denkvermogen dat hier-
voor nodig is heb ik aan jullie te danken. Jullie aanmoediging en vertrouwen waren een grote 
steun.
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